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Abstract 
Stress responses can be functional adaptions to help individuals cope with hassles by changing 
physiological processes during stressful episodes. In contrast, inadequate or excessive or too 
brief or prolonged stress responses can be harmful to the organism as stress has been shown to 
negatively impact on mental and physical health in the long term. Exposure to a stressor alters 
numerous biological functions with the hypothalamic-pituitary-adrenal axis and the autono-
mous nervous system accounting to the major human biological stress system.  Research on the 
effects of pharmacological as well as psychological interventions often used the standardized 
psychosocial stress test named Trier Social Stress Test to reliably induce acute stress in a la-
boratory setting in the major human stress systems. 
The emphasis of the current dissertation was to investigate two different interventions 
aiming to reduce physiological and emotional stress responses to the Trier Social Stress Test. 
Therefore, the thesis had two objectives: one was to examine the effects of the fixed herbal drug 
combination Ze 185 in men on stress responses of the hypothalamic-pituitary-adrenal axis and 
self-reported anxiety (Study I, Publication I) and of the autonomous nervous system (Study I, 
Publication II). The second goal was to investigate the effects of a social support stress man-
agement on stress responses in women assessing parameters of the hypothalamic-pituitary-ad-
renal axis, self-reported anxiety, and the autonomous nervous system (Study II, Publication III). 
For this reason, basic research approaches with healthy participants undergoing the Trier Social 
Stress Test and psychophysiological methods were chosen and applied in two randomized con-
trolled studies.  
The first study revealed that the participants receiving the fixed herbal drug reported 
reduced anxiety in comparison with the placebo (p = .03) and no treatment groups (p = .05) in 
response to the stress test while there were no significant differences in the biological stress 
response of the hypothalamic-pituitary-adrenal axis assessed with cortisol (p = .97; Study I, 
Publication I). In line with this, the parameters of the autonomous nervous system namely sal-
ivary alpha amylase (p = .51), heart rate (p = .17), heart rate variability (p = .56), skin conduct-
ance level (p = .18), and skin temperature (p = 0.65) did not differ significantly in the three 
study groups (Study I, Publication II). The second study revealed no significant differences in 
cortisol (p = .78), heart rate (p = .49), and heart rate variability (p = .53) levels in response to 
the stress test between the two conditions while participants in the social support stress man-
agement showed condition showed a significantly attenuated integrated self-reported anxiety 
response (p = .03) in comparison to those in the control condition. 
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In the second study participants in the social stress management and the waitlist control 
condition did not differ in their cortisol (p = .78), heart rate (p = .49), and heart rate variability 
(p = .53) reactions over time in response to the Trier Social Stress Test. Participants in the social 
support stress management showed a significantly attenuated integrated state anxiety response 
(p = .03) in comparison to those in the control condition.  
Both the fixed herbal drug combination and our social support stress management inter-
ventions attenuated the subjective emotional stress response in healthy participants and main-
tained the biological reactions in response to the standardized psychosocial stress test. How-
ever, as stress is a part of our daily lives, it is important to investigate and develop interventions 
supporting individuals to cope with stress to increase well-being during challenging episodes. 
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1. Theoretical Background 
1.1. Stress and biology of human stress responses 
Stress is conceptualized as the occurrence of life events that are interpreted by the person as 
undesirable and that represent a strain on the person’s adaptive capability causing an interrup-
tion of the person’s habitual functioning. Stress reflects those factors that interfere with the 
system’s physiological and psychological equilibrium (Ingram & Luxton, 2005). Furthermore, 
stress enables humans to adjust to challenging situations whereby the organism activates com-
pensator responses that functionally correspond to the stressor (von Dawans, Fischbacher, 
Kirschbaum, Fehr, & Heinrichs, 2012). Thus, stress responses can be functional and healthy 
adaptions to help individuals cope with daily hassles by changing physiological processes dur-
ing stressful episodes (McEwen, 1998; Sterling, 2004). In contrast, inadequate or excessive or 
too brief or prolonged stress responses as well as insufficient adaption can be harmful to the 
organism (Cacioppo, Tassinary, & Berntson, 2007).  
Various health and illness models emphasis stress as a possible contributing factor in 
the development of diseases (e.g., Ingram & Luxton, 2005; Wade & Halligan, 2017). For ex-
ample, the diathesis-stress model considers the combination of biological predispositions and 
environmental stressors in the development of psychological disorders. Thereby the model 
claims that if the combination of predispositions and the stress levels exceed a certain threshold, 
the individual experiences health-related impairments (Monroe & Simons, 1991). In line with 
that, several meta-analyses found negative impact on mental and physical health of stress 
(Booth et al., 2015; Toussaint, Shields, Dorn, & Slavich, 2016; Yu, Chiu, Lin, Wang, & Chen, 
2007). One of them demonstrated for example that perceived psychosocial stress was associated 
with increased risk for experiencing a stroke (Booth et al., 2015). The American Psychological 
Association’s (APA) Stress in America survey revealed that 20% of respondents stated extreme 
stress in their daily lives and 31% reported that their stress had increased in the past year. More-
over, 80% of respondents stated at least one physical and/or emotional symptom of stress over 
the past month (American Psychological Association, 2017). Furthermore, estimates indicate 
that between 75% and 90% of visits to primary care physicians are stress-related (Head & Kelly, 
2009).  
Exposure to an acute stressor alters numerous biological functions of human organisms 
and leads to the release of chemicals, which can help cope with the stressor (Allen, Kennedy, 
Cryan, Dinan, & Clarke, 2014). The two principal components of the adaptional stress response 
are the cortiocotropin-releasing hormone located in the hypothalamus and the locus cerluleus-
norepinephrine (LC-NE)/sympathetic system in the brain stem (Cacioppo et al., 2007; Chrousos 
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& Gold, 1992). The hypothalamic-pituitary-adrenal (HPA) axis and parts of the autonomous 
nervous system (ANS) are the afferent limbs of the stress system, whose central function is to 
maintain stress-related equilibrium (Cacioppo et al., 2007). 
 Looking at the HPA stress response, the paraventricular nucleus of the hypothalamus 
releases corticotropin-releasing factor which leads to the release of adrenocorticotropic hor-
mone from the pituitary gland followed by the secretion of cortisol from the adrenal gland. A 
significant increase in salivary cortisol following exposure to acute psychosocial stressor is well 
established (Allen et al., 2014; Cacioppo et al., 2007). Dysregulation of the HPA axis is asso-
ciated to adverse outcomes on somatic as well as to a wide range of outcomes on mental well-
being (Chrousos, 2009; Heim, Ehlert, & Hellhammer, 2000; Tirabassi, Muscogiuri, Colao, & 
Balercia, 2015). 
 The autonomous nervous system (ANS) is divided into two branches namely parasym-
pathetic and the sympathetic nervous system, which establish patterns of parasympathetic and 
sympathetic activation across the various physiological systems (Cacioppo et al., 2007). Fibers 
of the sympathetic nervous system release the neurotransmitter norepinephrine at the adrenal 
medulla and in consequence epinephrine, which both mediate different adaptive physiological 
processes to perfectly prepare the body for the fight-or-flight reaction. The adaption to acute 
stress on the cardiovascular system is reflected for instance as increased heart rate (HR) and 
blood pressure, as well as decreased heart rate variability (Chrousos & Gold, 1992). Another 
parameter of the ANS whose levels are increased under high autonomic activation is the en-
zyme salivary alpha amylase (sAA; Nater & Rohleder, 2009). Also, electro dermal activity as 
a measure of activity of sweat glands are innervated by the ANS (Allen et al., 2014; Jezova, 
Makatsori, Duncko, Moncek, & Jakubek, 2004; Rohrmann, Hennig, & Netter, 1999). Addition-
ally, changes in skin temperature (SKT) are controlled by the ANS though vasoconstriction and 
vasodilation of peripheral blood vessels (Ahmed, Begum, Funk, Xiong, & von Scheele, 2011; 
Karthikeyan, Murugappan, & Yaacob, 2012).  
One of the emotional responses to stress is represented by elevated anxiety levels. 
Thereby, the individual’s predisposition to respond and the stressful situation must be congru-
ent in order to evoke increases in state anxiety (Endler & Kocovski, 2001). One of the many 
definitions of the ambiguous construct anxiety is noted by (Lewis, 1969) as “an emotional state, 
with the subjectively experienced quality of fear as a closely related emotion” (p. 77). Together 
with the definition of Spielberger (1966) anxiety can be understood as an unpleasant emotion 
characterized by physiological arousal and perceived feelings of apprehension, dread, and ten-
sion (Endler & Kocovski, 2001). 
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Taken together, when experiencing acute stress, the human organism activates compensator 
responses in altering numerous biological functions regulated by the HPA and ANS to func-
tionally correspond to the stressor. Levels of salivary cortisol as a measure of the HPA axis and 
sAA, HR, and electro dermal activity as measures of ANS activation increase under stress while 
heart rate variability and distal SKT decrease (Allen et al., 2014; Castaldo et al., 2015; Vinkers 
et al., 2013). Furthermore, elevated subjective state anxiety levels as one of the emotional re-
sponses were found in acute stress situations (e.g., Britton, Shahar, Szepsenwol, & Jacobs, 
2012; Rosenkranz et al., 2013). 
 
1.2. Trier Social Stress Test 
The Trier Social Stress Test (TSST; Kirschbaum, Pirke, & Hellhammer, 1993) is an acute psy-
chosocial stress protocol used in research to experimentally induce HPA axis, ANS, and emo-
tional stress responses in a laboratory setting (Allen et al., 2014). The protocol provokes stress 
responses with combining high levels of social-evaluative threat and uncontrollability using a 
public speaking and a mental arithmetic task. The TSST is one of the most popular used stress 
tests and has been applied in a broad field of research. Research included for example investi-
gation of synthetic drugs (e.g. benzodiazepine; Fries, Hellhammer, & Hellhammer, 2006), 
sports (e.g. an endurance training; Klaperski, von Dawans, Heinrichs, & Fuchs, 2014), psycho-
logical interventions with an intraindividual focus (e.g. cognitive behavioral stress management 
training; Gaab et al., 2003; Hammerfald et al., 2006) as well as with an interindividual perspec-
tive (e.g. social interaction; Ditzen et al., 2007). The TSST has repeatedly been found to induce 
a reliable and profound psychophysiological stress responses in 70–80% of tested subjects with 
cortisol being most frequently assessed (Allen et al., 2014; Kirschbaum et al., 1993). 
The procedure of the TSST follows a standardized protocol suggested by Kirschbaum 
and colleagues (1993): Upon arrival, the participant rests in a quiet room A in order to help 
establish clear baseline measurements. After the resting period, the participant is taken to the 
TSST room B, where a selection committee consisting of one male and one female confederates 
is already sitting at a table with a video camera and a voice-recorder connected to a microphone 
visible for the participant. There, the task which the participant would have to perform subse-
quently is introduced during two minutes. The investigator asks the participant to take over the 
role of a job applicant who is invited for a personal interview with the staff managers (commit-
tee). After the introduction of the subsequent tasks the participant is guided back to room A for 
the preparation phase lasting for eight minutes. Then, the participant gives his or her speech in 
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front of the committee and followed by serially subtraction task for five minutes. Once com-
pleting the TSST exposure participant are guided into another room for recovery.  
 
1.3. Research on stress interventions with herbal medicinal products 
One approach to deal with stress reactions is the use of pharmacological treatments. Several 
synthetic drugs were investigated using the TSST to observe human stress responses under 
pharmacological treatment. For example, an antiepileptic drug that decreases glutamate release 
(Makatsori et al., 2004), an opioid partial agonist (Bershad, Jaffe, Childs, & de Wit, 2015), and 
benzodiazepine (Fries et al., 2006) were found to inhibit cortisol stress responses in comparison 
to placebo. Thereby there were no significant differences in HR and anxiety in the study with 
benzodiazepine (Fries et al., 2006). Despite their observed effectiveness to reduce stress re-
sponses, some pharmacological drugs can be associated with unwanted side effects and the risk 
of addiction and depend on compliance (e.g., Anthierens et al., 2010).  
Complementary and alternative medicine (CAM) for the treatment of psychological and 
physical problems is gaining more popularity (Roessler et al., 2007). For some individuals 
herbal medicinal products (belonging to phytotherapy) are appealing, considering their low risk 
of side effects and risks, at least in comparison with conventional pharmacological medicine 
which may be expressed in a higher compliance (Falch, Eltbogen, & Meier, 2013; Lynch & 
Berry, 2007). Herbal medicinal products differ from synthetic drugs in that they contain as 
active substance a plant preparation instead of a chemically precisely defined individual sub-
stance. Rational phytopharmaceutical drugs use plants and parts of plants for therapeutic pur-
pose meeting the requirements for quality, safety and efficacy for herbal medicinal products. 
This plant preparation (e.g. an extract) is composed of many different substances, so called 
multicomponent mixtures. Thus, in phytotherapy, the extract as a whole is the active ingredient. 
As mentioned, they underlie the requirements of the Drug Law regarding quality, efficacy, and 
safety for evidence-based products (Wagner & Wiesenauer, 2003). One advantage of herbal 
medicinal products is their broad spectrum of pharmacological targets: as herbal multicompo-
nent mixtures, they interact with several biochemical structures instead of having a single effect 
on one biochemical mechanism. Although the onset of action may often need more time, the 
curative treatment is possibly more thorough and comprehensive (Falch et al., 2013).  
Considering the empirical status of herbal medicinal products for the treatment of stress 
and stress-reactivity, a number of randomized placebo-controlled trials indicate the potential of 
herbal drugs. A randomized-controlled study demonstrated reduced HR responses in partici-
pants taking tablets of valerian (LI 156; Sedonium, containing 300 mg ethanolic dried valerian 
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root extract; drug/extract ratio 3-6:1; Cropley, Cave, Ellis, & Middleton, 2002). In addition, a 
randomized-placebo controlled study with a combination of Melissae officinalis L. and Valeri-
ana officinalis L (each tablet containing 120 mg of Valeriana officinalis extract; drug/extract 
ratio 4,5:1 and 80 mg of Melissa officinalis extract; drug/extract ratio 5:1; Songha Night™) 
reduced anxiety in healthy individuals undergoing cognitive tasks with the 600 mg dose of the 
combination (Kennedy, Little, Haskell, & Scholey, 2006). Also, treatment with another combi-
nation remedy (Sandrin® containing 320 mg of the quantified dry extract WS 1014 from vale-
rian root; drug/extract ratio 3–6: 1; solvent ethanol 62% (m/m)) and 160 mg of the quantified 
lemon balm dry extract WS 1303 (drug/extract ratio 4–6:1; solvent ethanol 30% (m/m)) reduced 
anxiety in preschool children with concentration difficulties reported by parents (Gromball, 
Beschorner, Wantzen, Paulsen, & Burkart, 2014). Moreover, reduced stress-related symptoms 
were found in participants with anxiety disorder taking capsules with a standardized, hydroal-
coholic Melissa officinalis L. leaf extract with the 600 mg dose of the combination (300 mg; 
Cases, Ibarra, Feuillere, Roller, & Sukkar, 2011). A Passiflora incarnata L. extract (424 mg; 
drug/extract ratio 5:1-7:1; extraction solvent: ethanol 50%) increased stress resistance after 12 
weeks of treatment in patients with nervous restlessness (Gibbert, Kreimendahl, Lebert, Rych-
lik, & Trompetter, 2017). Previous research with the fixed herbal drug combination Ze 185, 
containing extracts of Petasites hybridus (L.) P. Gaertn, Valerianae officinalis L., Passiflora 
incarnata L., and Melissa officinalis L., decreased anxiety levels in healthy participants after 
cognitive tasks in a randomized-placebo controlled study (Steiner & Opwis, 2000), as well as 
in patients with psychosomatic complaints (Schellenberg, Sauer, & Brattström, 2004). Herbal 
preparations containing Passiflora incarnata L., Melissa officinalis L. as well as Valeriana of-
ficinalis L. have been traditionally used for the relief of mild symptoms of mental stress, as-
sessed by the Committee on Herbal Medicinal Products (HMPC) of the European Medicines 
Agency (HMPC 2013, 2014, 2016). On the basis of the empirical evidence so far as well as 
considering their acceptability and apparent safety, herbal medicinal products warrant further 
scientific examination.  
 
1.4. Research on stress interventions and social support 
Another approach to deal with stress is the use of social support which was investigated in 
previous research (Burton, Bonanno, & Hatzenbuehler, 2014; Ditzen et al., 2008; Heinrichs, 
Baumgartner, Kirschbaum, & Ehlert, 2003). Positive social interactions are crucial for both 
physiological and psychological well-being and health (Holt-Lunstad, Smith, & Layton, 2010; 
Jenkins & Elliott, 2004). A meta-analysis including 148 studies investigated the influence of 
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social relationships on risk for mortality and detected a 50% increased likelihood of survival 
for participants with stronger social relationships (Holt-Lunstad et al., 2010). In addition, a 
study with long-term nursing stuff reported that support from supervisors, coworkers, spouses 
friends or family members was associated with less emotional exhaustion and higher levels of 
personal accomplishment (Woodhead, Northrop, & Edelstein, 2016). Amongst the many con-
ceptualizations of social support, Wills (1991) defined it as the perception or experience that 
one is loved and cared for by others, esteemed and valued, and part of a social network of 
mutual assistance and obligations (Taylor, 2011). Thus, social support can involve helping an-
other person to understand a stressful event better, provision of specific aid or goods, as well 
as providing warmth and reassurement of the other person’s value. To conclude, social support 
involves the perception of available resources should they be needed (Taylor, 2011).  
Presented in a review, Christenfeld and Gerin (2000) described several studies in which 
social support was associated with reduced cardiovascular reactivity under stress. Investigating 
stress responses induced by the TSST, several studies reported suppressed cortisol stress re-
sponses in participants having positive social interactions before stress exposure (Burton et al., 
2014; Ditzen et al., 2008; Heinrichs et al., 2003). Previous studies with an interindividual per-
spective included e.g. healthy male participants receiving social support from the participant’s 
best friend (Heinrichs et al., 2003), from the partner (Ditzen et al., 2008), and individuals re-
ceiving family as well as peer support (Burton et al., 2014). Interestingly, greater levels of fam-
ily support were associated with diminished cortisol stress reactivity while peer support was 
not associated with the neuroendocrine response (Burton et al., 2014). Furthermore, social sup-
port from a same-gender stranger during the TSST preparation phase was associated with equiv-
alent cortisol and cardiovascular reactions in participants who received no support in a healthy 
sample (Robles, 2007). Moreover, a study with healthy individuals including partner as well as 
stranger support revealed different results for men and women. While men in the partner-sup-
ported group experienced reduced cortisol peak responses compared to those in the stranger 
and no support groups, women in the partner-supported group showed higher cortisol responses 
than those in the stranger support group (Kirschbaum, Klauer, Filipp, & Hellhammer, 1995). 
In a more recent study, women that were verbally supported by their partners before the TSST 
showed elevated cortisol and HR stress responses. In contrast, healthy women experiencing 
positive physical partner contact prior the TSST exhibited significantly lower cortisol and HR 
responses compared to women who received verbal support from their partners or no social 
interaction (Ditzen et al., 2007). Furthermore, in healthy women completing a mental arithmetic 
task, support from a male friend was associated with attenuated blood pressure reactivity while 
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support from a female friend or a male stranger was associated with augmented blood pressure 
reactivity (Phillips, Gallagher, & Carroll, 2009). Although not applying the TSST, a previous 
study evaluated the effects of an intervention employing the buffering effect of social support 
and revealed no effects on emotional as well as cardiovascular reactivity to a psychosocial 
stressor (Anthony & O’Brien, 2002). 
 
 
2. Aims of the thesis 
The thesis had the main goal to investigate two different interventions aiming to reduce emo-
tional and physiological stress responses to an acute psychosocial stress test in healthy individ-
uals. Therefore, the thesis had two objectives: one was to examine the effects of the fixed herbal 
drug combination Ze 185 on human emotional and physiological stress responses in men. The 
second goal was to investigate the effects of a social support stress management on emotional 
and physiological stress responses in women. For this reason, basic research approaches with 
healthy participants and psychophysiological methods were chosen and applied in two experi-
mental studies both applying the TSST. Psychophysiological methods are able to enhance our 
understanding of basic psychophysiological processes being part of the human stress responses. 
Furthermore, they provide a systematic approach to empirically investigate the effects of spe-
cific treatments aimed at reducing human stress responses.   
Two studies described in this thesis were developed to answer following research ques-
tions. The results of Study I are presented in two publications with Publication I reporting re-
sults on salivary cortisol and state anxiety and Publication II reporting results on ANS param-
eters.  
 
(1) What effects does the fixed herbal drug combination Ze 185 have in healthy partic-
ipants undergoing the TSST in regards of emotional and physiological stress re-
sponses compared to placebo and no treatment? 
 
Study I. Herbal medicinal products are appealing, with low incidence of adverse drug reactions 
and a well benefit-risk ratio (Lynch & Berry, 2007). Considering the empirical status of herbal 
medicinal products for the treatment of stress and stress-reactivity, a number of randomized 
placebo-controlled trials indicate the potential of this approach. However, research on the ef-
fects of the fixed herbal combination Ze 185 with assessment of the major biological stress 
systems, namely the HPA axis and the ANS using a standardized acute psychosocial stressor, 
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is missing. Thus, the goal of Study I was to investigate emotional stress responses with self-
reported state anxiety and physiological stress responses with assessments of salivary cortisol, 
sAA, HR, heart rate variability, skin conductance level, and SKT in healthy participants under 
the intake of Ze 185.  
 
(2) What effects does a social support stress management have in healthy women un-
dergoing an acute psychosocial stress test in regards of emotional and physiological 
stress responses? 
 
Study II. Previous research has confirmed beneficial effects of positive social interactions on 
stress responses (e.g., Burton et al., 2014; Ditzen et al., 2008). One study observed the effects 
of a short intervention employing the buffering effect of social support, albeit with no effects 
on an array of psychological parameters as well as cardiovascular reactivity to a psychosocial 
stressor (Anthony & O’Brien, 2002). Hence, the goal in Study II was to conceptualize, imple-
ment and evaluate the effects of a social support stress management intended to employ and 
improve social support skills and to reinforce the stress buffering effect of social support on 
emotional and psychophysiological  stress responses in women.  
 
 
3. Methods 
3.1. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress 
setting in healthy men – an explorative randomized placebo-controlled double blind 
study (Study I, Publication I) 
Participants. Healthy male participants aged between 18 and 45 years from the general 
Swiss population were recruited via online advertisements on www.markt.unibas.ch between 
January 2015 and June 2016. The screening procedures were conducted at the University Hos-
pital of Basel by a medical team. Exclusion criteria were the presence of somatic or psychiatric 
disorders, or any other clinically relevant diseases, as well as the intake of medication, smoking, 
previous participation in a TSST, and being currently in any psychotherapy.  
Procedure. Participants were randomly assigned to the fixed herbal combination Ze 
185 (n = 24), placebo (n = 24), and no treatment (n = 24). Participants as well as the study team 
were blind regarding group allocation. During the first three days of the study participation all 
participants completed online questionnaires at home and the two medication groups took three 
tablets per day. The Ze 185 and placebo tablets were identical in presentation, color, and shape. 
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On the fourth day all participants underwent the TSST at the division of Clinical Psychology 
and Psychotherapy of the University of Basel. Thereby, salivary cortisol, self-reported anxiety, 
sAA, HR, heart rate variability, electro dermal activity, and SKT parameters were assessed 
before, during and after the stress test. The end of the study visit was conducted three to five 
days later at the University Hospital of Basel.  
  Outcome measures. On the fourth day at the division of Clinical Psychology and Psy-
chotherapy, the saliva cortisol levels were assessed eleven times in total, four times before the 
TSST and seven afterwards. The first assessment was intended to help the participants getting 
used to the procedure and was not included in the analyses. The mean value of the second and 
third saliva collection was used as baseline assessments. The first post TSST saliva collection 
was conducted right after the TSST completion and the last one 90 minutes after the TSST. 
Saliva samples were collected using polypropylene saliva tubes (Sarstedt, Nümbrecht, Ger-
many). Salivary free cortisol was assayed using the Salimetrics immunoassay method (EIA kits; 
Salimetrics LLC, USA). All samples were analyzed by the Swiss-Analysis AG (Tägerwilen, 
Switzerland). The assay kits had an intra-assay variation of 3 to 7% and inter-assay variation 
of 3 to 11%. The minimum detectable level of cortisol concentration was 0.007 µg/dL.  
  As emotional stress response, self-reported state anxiety was assessed with the State-
Trait Anxiety Inventory (STAI; Laux, Glanzmann, Schaffner, & Spielberger, 1981) four times 
in total. One assessment took place before the TSST as baseline measurement (45 minutes prior 
to the TSST) and three assessments after the stress test (directly after TSST completion; ten 
minutes post TSST completion; 30 minutes post TSST completion) The STAI-state part con-
sists of 20 items rated on a four-point scale with 1 = ”not at all” and 4 = “very much” and has 
acceptable internal consistency and test-retest reliability (Lee, Park, & Moon, 2004). 
Statistical analyses. Analyses were performed with the IBM SPSS Version 21 (IBM 
Corperation, 2012). The shown analyses are based on the Intention to Treat (ITT) dataset. Data 
were tested for normal distribution using Kolmogorov–Smirnov test. Cortisol, state anxiety, 
and baseline variables were log-transformed to approximate normal distribution. For better 
readability, the original values were used for Tables and Figures. Baseline characteristics of the 
study groups were compared with one-way analyses of variance or Chi-square tests. Analysis 
of variance for repeated measures were computed to analyze cortisol and state anxiety responses 
between the study groups. Post hoc analyses were examined with separate analyses of variance. 
Additionally, area under the curve with respect to increase (AUCI) and area under the curve 
with respect to ground (AUCG) were calculated for cortisol data using the trapezoidal method 
(Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003). Post hoc analyses were 
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examined with separate analyses of variance.  
 
3.2. Autonomic nervous system stress response under the intake of the fixed herbal drug 
combination Ze 185: a placebo-controlled randomized trial with healthy men (Study I, 
Publication II) 
 Participants and Procedure. For the description of study participants and data analy-
sis kindly refer to the description under 3.1. 
Outcome measures. On the fourth day at the division of Clinical Psychology and Psy-
chotherapy, eleven saliva samples were collected leading to two sAA values before the TSST 
and seven after the TSST (until 90 minutes post TSST). The first saliva collection was not 
included in the analyses as the intention was for the participants getting used to the procedure. 
Baseline sAA values were calculated as the mean values of the second and third assessment. 
Completely defrosted saliva samples were vortexed and subsequently centrifuged at 1500 x g 
(3000rpm) for 15 minutes. The centrifuged saliva samples were diluted 1:200 by first diluting 
samples 1:10 with the alpha amylase diluent provided followed by a 1:20 dilution of the 1:10 
diluent sample resulting in a final dilution of 1:200. Intra-assay and inter-assay coefficients of 
variation were less than 7.3%. and 5.9%, respectively. All samples were analyzed by Swiss-
Analysis AG (Tägerwilen, Switzerland). 
Furthermore, HR, heart rate variability, electro dermal activity, and SKT were continu-
ously recorded during the whole visit. Heart rate variability was assessed with the square root 
of the mean of the sum of the squares of differences between adjacent normal-to-normal inter-
vals (RMSSD). Electro dermal activity was assessed with skin conductance level (SCL). All 
ANS parameters were assessed with the wireless physiological recording system BioNo-
madix® (Biopac Systems, Inc., Santa Barbara, CA 93117) allowing subjects to move freely. 
For each parameter, the same five minutes intervals were measured at seven time points: at 
baseline (-35 minutes before TSST completion), preparation directly after the TSST introduc-
tion (-17 minutes before TSST completion), TSST speech (first five minutes of the TSST), 
TSST arithmetic task (second five minutes of the TSST), recovery 1 (five minutes after TSST 
completion), recovery 2 (20 minutes after TSST completion), and recovery 3 (25 minutes after 
TSST completion). After data collection, HR and RMSSD parameters were derived with the 
VivoSense® software (VivoNoetics, US). SCL and SKT was derived with the Ac-
qKnowledge® software (Biopac Systems Inc.) 
Statistical analyses. Statistical analyses were performed with the IBM SPSS Version 
21 (IBM Corperation, 2012). The shown analyses are based on the Intention to Treat (ITT) 
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dataset. Data were tested for normal distribution using Shapiro-Wilk test. sAA variables were 
square-root-transformed and HR, RMSSD, SCL, and SKT variables were log transformed to 
approximate normal distribution. For better readability, the original values were used for Tables 
and Figures. Analysis of variance for repeated measures were computed to compare sAA, HR, 
RMSSD, SCL, and SKT data between the three study groups. For effect sizes, partial eta square 
were reported, where appropriate, according to the following conventions: 0.01 = small, 0.06 = 
medium, 0.13 = large (J. Cohen, 1988). Regarding electrophysiological measures, artifacts, 
loosening electrodes and technical problems resulted in a loss of data from single subjects, 
resulting in different n. 
 
3.3. Randomized controlled evaluation of the psychophysiological effects of social sup-
port stress management in healthy women (Study II, Publication III) 
Participants. Healthy female participants from the general Swiss population were re-
cruited in lectures and via online advertisements at the University of Basel and the university 
of Applied Sciences and Arts of Northwestern Switzerland. Some researchers suggested that 
females’ behavioral stress response is next to the typical fight-or-flight stress response addi-
tionally marked by a pattern of “tend and befriend” (Taylor et al., 2000). Thus, we assumed 
women to readily accept the rational of the social support stress management, which would 
facilitate the implementation of the intervention. Additionally, participants had to be aged be-
tween 18 and 60 years. Exclusion criteria were any current or chronic somatic diseases or psy-
chiatric disorders, current medication, being in psychological treatment, previous participation 
in studies using the TSST, and smoking more than five cigarettes a day.  
Procedure. A total of 53 participants fulfilled inclusion criteria and were randomly as-
signed to the intervention (n = 28) and waitlist control condition (n = 25). Due to withdrawal 
before the intervention (intervention condition n = 2, waitlist control condition n = 4), insuffi-
cient intervention attendance (intervention condition n = 5), not completing post-training as-
sessment (intervention condition n = 1, waitlist control condition n = 1) and refusing participa-
tion in the TSST (intervention condition n = 0, waitlist control condition n = 3) the sample 
completing the TSST consisted of n = 37: n = 20 in the intervention and n = 17 in the waitlist 
control condition. After the screening procedure, participants in the intervention condition re-
ceived a two-week social support stress management in groups of five to seven participants 
(week 2 and 3). The control condition was a waiting list condition with participants receiving 
the intervention after all the measurements were completed (week 8). All participants from both 
conditions underwent the TSST (week 5 to 7). Self-report questionnaires were completed online 
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at baseline (week 1), post-training (week 4) and follow-up (week 8). At the TSST visit (week 
5 to 7) at the division of Clinical Psychology and Psychotherapy of the University of Basel, 
salivary cortisol levels, HR, RMSSD, and self-reported anxiety were assessed.  
Outcome measures. Nine saliva samples were collected using Salivette collection de-
vices (Sarstedt, Sevelen, Switzerland): three before the TSST and five after the TSST (time 
points ranging from right after the TSST to 50 minutes post TSST). Biochemical analyses were 
conducted in the biochemical laboratory of the Clinical Psychology and Psychotherapy depart-
ment at the University of Zurich, Switzerland. A highly sensitive liquid chromatography–tan-
dem mass spectrometry (LC–MS/MS) method was used (Perogamvros et al., 2009).  
HR and RMSSD were continuously assessed during the whole TSST visit using the 
wireless physiological recording system BioNomadix® (Biopac Systems, Inc., Santa Barbara, 
CA 93117) and derived with the VivoSense® software (VivoNoetics, US). For HR and 
RMSSD, the same five minutes intervals were measured at seven time points: baseline (-30 
minutes before TSST completion), preparation directly after the TSST introduction (-17 
minutes before TSST completion), TSST speech (first half of the TSST), TSST arithmetic task 
(second half of the TSST), recovery 1 (five minutes after TSST completion), recovery 2 (15 
minutes after TSST completion), and recovery 3 (25 minutes after TSST completion). 
Additionally, emotional stress responses were assessed with self-reported state anxiety 
using the STAI (Laux et al., 1981) before the TSST (-45 minutes), after the introduction to the 
TSST (-20 minutes), immediately after the TSST (0 minutes) and in the recovery phase (50 
minutes). For the description of the STAI questionnaire kindly refer to 3.1.  
Next to the evaluation of the social support stress management in the TSST, we also 
observed psychometric parameters as well as feasibility and applicability of the social support 
stress management in the longer-term with self-reported questionnaires (e.g. Perceived Stress 
Scale; S. Cohen, Kamarck, & Mermelstein, 1983; Working Alliance Inventory; Wilmers et al., 
2008). Participants filled in those questionnaires online several weeks before and after comple-
tion of the TSST (baseline week 1, post-training week 4 and follow-up week 8). This thesis 
focuses on effects under acute psychosocial stress and therefore data is not shown here.  
Statistical analyses. Statistical analyses were performed with the IBM SPSS Statistics 
Version 23 (IBM Corperation, 2015). The shown analyses are based on the sample who com-
pleted the TSST visit (n = 37: n = 20 in the intervention and n = 17 in the waitlist control 
condition). Due to technical problems during the TSST visit there is a loss of data from single 
subjects, resulting in different n (state anxiety n = 35; cortisol n = 37; HR and RMSSD n =  34). 
Two subjects had missing HR values at baseline, which were replaced with the arithmetical 
  15 
mean of the recovery values. Three subjects showed missing values in one or two recovery 
assessments which were replaced with the arithmetical mean of the available recovery values. 
State anxiety, salivary cortisol, HR, and RMSSD were tested for normal distribution and ho-
mogeneity of variance using the Kolmogorov-Smirnov test before statistical procedures were 
applied. When normal distribution was violated, calculations were repeated with log trans-
formed data. For better readability, the original values were used for Tables and Figures. Anal-
ysis of covariance for repeated measures were computed to analyze state anxiety, cortisol, HR, 
and RMSSD responses between the study groups with age as covariate. Additionally, body 
mass index (BMI) was included as covariate in the analyses of the physiological parameters. 
For state anxiety and cortisol AUCI were calculated using the trapezoidal method (Pruessner et 
al., 2003) as an indicator for the integrated stress response in the TSST. AUCI values were 
compared with univariate analyses of covariance with age and for cortisol analysis together 
with BMI included as covariables. For effect sizes, partial eta square were reported, where ap-
propriate, according to the following conventions: 0.01 = small, 0.06 = medium, 0.13 = large 
(J. Cohen, 1988). 
 
 
4. Summary of the results 
4.1. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress 
setting in healthy men – an explorative randomized placebo-controlled double blind 
study (Study I, Publication I) 
Out of the 72 randomized participants two dropped out after randomization but before receiving 
study medication. The remaining 70 participants had a mean age of 26.07 years (SD = 5.17), a 
mean BMI of 24.41 kg/m2 (SD = 2.88) and with 96.3% the majority was Caucasian. The 
study groups did not differ with respect to any of the assessed demographic variables in age 
(F(2, 67) = 1.08, p = .35), BMI (F(2, 67) = 0.05, p = .96), distribution of ethnicity (c2(4, N = 
70) = 4.02, p = .40). 
 The TSST induced significant and substantial increases in salivary cortisol levels (F(8, 
60) = 40.28, p < .001). Cortisol levels among all participants did not differ between the three 
groups at baseline (F(2, 67) = 0.05,  p= .95) and groups did not differ significantly in their 
cortisol responses over time (F(16, 122) = 0.43, p = .97) nor did integrated cortisol responses 
(AUCI: F(2, 67) = 0.17, p = .84; AUCG: F(2, 67) = 0.002, p = .99). Groups did not differ sig-
nificantly in state anxiety baseline scores (F(2, 67) = 0.50, p = .61) and the TSST resulted in a 
significant state anxiety response (F(3, 64) = 25.89, p < .001). Groups differed however 
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significantly in the state anxiety response over time (F(6, 130) = 2.41, p = .03) and post hoc 
analyses revealed a significant time by group interaction effect between placebo and Ze 185 
(F(3, 41) = 3.33, p = .03), as well as between no treatment and Ze 185 (F(3, 43) = 2.77, p = .05) 
while response differences between no treatment and placebo were not significant (F(3, 42) = 
1.42, p = .25).   
 
4.2. Autonomic nervous system stress response under the intake of the fixed herbal drug 
combination Ze 185: a placebo-controlled randomized trial with healthy men  
 (Study I, Publication II) 
Kindly refer to 4.1. for a description of the participant’s demographic information. The TSST 
induced a significant increase in sAA levels (F(8, 60) = 28.17, p < .001, partial eta square = 
.79). sAA levels did not differ between the three groups (Ze 185 n = 23, placebo n = 23, no 
treatment n = 24) at baseline (F(2, 67) = 0.05, p = .95) as well as over time (F(16, 122) = 
0.95, p = .51). There were no significant differences in HR values at baseline (F(2, 52) = 2.26, 
p = .11) between the groups (Ze 185 n = 17, placebo n = 18, no treatment n = 20). The TSST 
induced significant and substantial increases in HR levels (F(6, 47) = 55.17, p < .001,  partial 
eta square =  .88). HR levels did not differ between the three groups over time (F(12, 96) = 
1.42, p = .17). The TSST induced significant and substantial decreases in RMSSD levels (F(6, 
47) = 6.95, p < .001, partial eta square = .47). RMSSD levels did not differ between the three 
groups (Ze 185 n = 17, placebo n = 18, no treatment n = 20) at baseline (F(2, 52) = 0.54, p = 
.58) and over time (F(12, 96) = 0.90, p = .56). The TSST induced significant and substantial 
changes in SCL (F(6, 44) = 27.64, p < .001,  partial eta square = .79). SCL did not differ be-
tween the three groups (Ze 185 n = 20, placebo n = 14, no treatment n = 18) at baseline (F(2, 
49) = 0.54, p = .59) and over time (F(12, 90) = 1.39, p = .18). The TSST induced significant 
changes in SKT (F(6, 57) = 104.74, p < .001, partial eta square = 0.92). The SKT did not dif-
fer between the three groups at baseline (F(2, 65) = 0.87, p = .42) and there were no signifi-
cant time by group interaction effects (F(12, 116) = 0.80, p = .65).  
 
4.3. Randomized controlled evaluation of the psychophysiological effects of social sup-
port stress management in healthy women (Study II, Publication III) 
Participants completing the TSST (n = 37) had a mean age of 29.51 years (SD = 12.50) and a 
mean BMI of 21.23 kg/m2 (SD = 2.68). There was no significant difference in BMI between 
the two groups (t(23.84) = -.11, p = .914). There was a significant group difference in age with 
subjects in the control group being significantly older than subjects in the intervention condition 
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(t(19.15) = -3.57, p = .002); intervention condition M = 23.35, SD = 5.03, waitlist control con-
dition M = 36.76, SD = 14.77). 
With regard to state anxiety (n = 35), there were no significant baseline differences be-
tween the two conditions (intervention condition M = 38.15, SD = 8.50; waitlist control condi-
tion M = 35.53, SD = 5.16; t(35) = 1.11, p = .28). With regard to state anxiety responses to the 
TSST, participants in the intervention condition showed a trend to an attenuated response over 
time (n = 35; F(2.87, 91.81) = 2.59, p = .06, partial eta square = .08) as well as a significant 
lower integrated response in comparison to waitlist control condition (AUCI: intervention con-
dition M = 153.21, SD = 515.26; waitlist control condition M = 592.63, SD = 910.22; F(1, 32) 
= 5.51, p = .03, partial eta square = .15).  
Cortisol levels among all participants did not differ between the two conditions (n = 37) 
at baseline (intervention condition M = 4.68, SD = 3.43; waitlist control condition M = 4.74, 
SD = 2.98, t(35) = -0.06, p = .95). There was no significant difference between groups in their 
cortisol response over time (F(2.02, 66.65) = 0.25, p = .78). Similarly, integrated cortisol stress 
responses did not differ significantly between conditions (AUCI: intervention condition M = 
53.51, SD = 198.18; waitlist control condition M = 38.89, SD = 171.01, F(1, 33) = 0.11, p = 
.74). 
Conditions did not differ in baseline HR (n = 34; intervention condition M = 74.51, SD 
= 10.14; waitlist control condition M = 71.12, SD = 11.19; t(32) = 0.93, p = .36) and baseline 
RMSSD (n = 34; intervention condition M = 53.10, SD = 23.88; waitlist control condition M = 
42.53, SD = 23.01; t(32) = 1.31, p = .20). Also, participants in both conditions did not differ 
significantly in their HR (F(1.69, 50.63) = 0.67, p = .49) nor in RMSSD responses to the TSST 
(F(1.99, 59.56) = 0.65, p = .53). 
 
 
5. Discussion 
The first objective of this thesis was to assess the effects of the fixed herbal drug combination 
Ze 185 on emotional and physiological responses to acute psychosocial stress in healthy men 
(Study I). Given that individuals demonstrate stress-relieving responses in trials with herbal 
medicinal products and the low risk of side effects and risks compared to conventional medic-
inal drugs, it is important to evaluate the potential of the fixed herbal drug combination in a 
three-arm trial using a standardized acute psychosocial stress test. In regard of the second ob-
jective of this thesis, previous research demonstrated promising results showing benefits of 
social support in stressful situations. Therefore, it is important to implement a social support 
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stress management under acute psychosocial stress. Thus, a further goal of this thesis was to 
evaluate the effects of a social support stress management intended to employ and improve 
social support skills in women in terms of biological and emotional responses to a standardized 
acute psychosocial stress test (Study II).  
Results of the randomized placebo-controlled study with Ze 185 (Study I) showed that 
the fixed herbal drug combination significantly attenuated subjective state anxiety responses 
after acute psychosocial stress in healthy men compared to the placebo and no treatment groups, 
without affecting the parameters of the biological stress response system. Results of the effects 
of the social support stress management (Study II) revealed no significant different biological 
stress responses to the standardized psychosocial stress test, albeit the intervention condition 
showed a significantly attenuated state anxiety response in comparison to the control condition. 
 
5.1. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress 
setting in healthy men – an explorative randomized placebo-controlled double blind 
study (Study I, Article I) 
In line with our findings, other randomized-placebo controlled trials investigating herbal inter-
ventions have reported decreases in anxiety in healthy subjects (Kennedy et al., 2006; Lee et 
al., 2004). Participants who experienced stress by completing cognitive tasks reported dimin-
ished anxiety levels after the intake of Melissae officinalis and Valeriana officinalis (Kennedy 
et al., 2006). Investigated in a naturally setting, Ondamatanggamibang, a Korean traditional 
herbal remedy, reduced anxiety in medical students experiencing naturally occurring stress due 
to academic examination (Lee et al., 2004). Previous research with Ze 185 did not include in-
ducement of acute psychosocial stress in healthy participants. Nevertheless, reduced anxiety 
was found under the intake of Ze 185 in participants experiencing stress induced by completing 
cognitive tasks (Steiner & Opwis, 2000). Although not observing acute stress situation, the 
treatment with Ze 185 reduced general self-reported anxiety in patients with psychosomatic 
complaints (Schellenberg et al., 2004) and with somatoform disorders (Melzer, Schrader, Bratt-
ström, Schellenberg, & Saller, 2009). Noteworthy, several psychological and pharmacological 
interventions had no effect on self-reported anxiety in response to stress, including a psycho-
logical intervention designed to shift goal orientation from self-promotion to helping others 
(Abelson et al., 2014) and 1 mg of alprazolam (Fries et al., 2006). 
Similar to our results, a number of trials demonstrated a dissociation of emotional and 
biological stress responses, i.e. reduced anxiety responses in face of no decrease in cortisol 
responses (self-compassion training; Arch et al., 2014; mindfulness meditation; Creswell, 
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Pacilio, Lindsay, & Brown, 2014; compassion meditation; Pace et al., 2009; brief attentional 
training; Pilgrim, Ellenbogen, & Paquin, 2014; aromatherapy; Takeda, Tsujita, Kaya, 
Takemura, & Oku, 2008). Noteworthy, the adaptive function of increased cortisol levels has 
been highlighted in a recent study. The authors report that elevated cortisol responses in the 
TSST were associated with fewer errors in threat-related decision making in police officers 
(Akinola & Mendes, 2012). Moreover, higher cortisol levels were associated with subsequent 
increased activeness, and relaxation, and reductions in perceived stress in everyday life (Hoyt, 
Zeiders, Ehrlich, & Adam, 2016). One possible explanation for the dissociation of subjective 
and objective stress responses could be the assumption of an important functionality of cortisol 
stress responses, which may serve to support positive and/or protect against negative emotional 
responses.  
Additionally in line with previous trials of this fixed herbal drug combination (Schel-
lenberg et al., 2004; Steiner & Opwis, 2000), herbal interventions, such as Ze 185, appear to be 
specifically effective in reducing subjective anxiety and anxiety responses to stress without 
affecting the HPA axis stress response system. The mechanism of action of Ze 185 is not fully 
understood. However, for valerian, passion flower and lemon balm anxiolytic effects have been 
suggested in several preclinical studies. A possible mechanism for certain constituents from 
valerian could be the modulation of the Gamma-Aminobutyric acid (GABA)A receptor (e.g. 
valerenic acid; Becker, Felgentreff, Schröder, Meier, & Brattström, 2014). In addition, a glu-
tamatergic mechanism has been suggested (Del Valle-Mojica et al., 2011). Regarding passion 
flower and lemon balm, anxiolytic effects have been suggested to be mediated also via the 
GABAergic system (Grundmann, Wang, McGregor, & Butterweck, 2008; Ibarra, Feuillere, 
Roller, Lesburgere, & Beracochea, 2010).  
 
5.2. Autonomic nervous system stress response under the intake of the fixed herbal drug 
combination Ze 185: a placebo-controlled randomized trial with healthy men  
Men (Study I, Article II) 
Previous studies on herbal medicinal products predominantly considered HPA activity with 
assessments of cortisol levels (e.g. al'Absi et al., 2013; Lee et al., 2004). Despite sAA is a pop-
ular biomarker of ANS in stress research in the context of psychological interventions (e.g. 
Thoma et al., 2013) and synthetically drugs (e.g. van Veen et al., 2009), research on herbal 
medicinal products has made limited use of sAA. However, our results of an increase in sAA 
and a decrease in distal SKT in participants being confronted to the TSST are in line with pre-
vious research (Allen et al., 2014; Het, Schoofs, Rohleder, & Wolf, 2012; Vinkers et al., 2013).  
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Furthermore, studies observing the effects of herbal medicinal products on cardiovascular pa-
rameters produced mixed results and thus were less convincing. In line with our results, a ran-
domized placebo controlled study investigating HR in response to a dentist surgery demon-
strated no significant differences between participants taking either 100 mg valerian or placebo 
capsules (Pinheiro, Alcântara, de Moraes, & de Andrade, 2014). In contrast, another random-
ized controlled study reported reduced HR responses within subjects in response to a mental 
stress task after taking tablets containing valerian with the 600 mg dose of the combination (LI 
156; Sedonium, containing 300 mg ethanolic dried valerian root extract; drug/extract ratio 3-
6:1; Cropley et al., 2002). However, none of those studies applied psychosocial stress and only 
one study (Pinheiro et al., 2014) included a placebo control group.  
Our results demonstrate that participants exhibited a significant stress response in the 
ANS parameters. The results of the ANS parameters are in line with those of the other major 
biological stress system (e.g. HPA axis) assessed with salivary cortisol (Study I, Publication 
II). The findings suggest that the response of the ANS to acute psychosocial stress is maintained 
with Ze 185 and similar compared to placebo and no treatment. Considering the effects on self-
reported emotional parameters and their high acceptability and low risks (e.g. Meier et al., 2018; 
Melzer et al., 2009), further studies on the effects of herbal medicinal products are warranted 
to investigate who might benefit from these products and for which conditions. 
 
5.3. Randomized controlled evaluation of the psychophysiological effects of social sup-
port stress management in healthy women (Study II, Article III) 
In line with previous studies, our findings show that the TSST elicited an increase in state anx-
iety, cortisol, HR and a decrease in RMSSD (Allen et al., 2014). Moreover, previous research 
on psychological interventions with intraindividual focus found reduced self-reported anxiety 
stress responses in the TSST as well. Hoge et al. (2013) have demonstrated that participants 
experienced a larger reduction in anxiety responses after they underwent a mindfulness-based 
stress reduction program than an attention control group to repeated TSST confrontation. Like-
wise, participants in a mindfulness-based cognitive therapy group showed significantly de-
creased anxiety responses to the TSST when compared to pre-intervention levels whereas there 
were no differences in the control condition (Britton et al., 2012).  
Moreover and similar to our results, a number of studies with interventions with an in-
traindividual perspective reported reduced anxiety responses in face of unaltered cortisol re-
sponses (e.g. self-compassion training; Arch et al., 2014; mindfulness meditation; Creswell et 
al., 2014). However, opposed to this, several randomized-controlled trials with an 
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intraindividual (e.g. cognitive behavioral stress management training; Gaab et al., 2003; 
Hammerfald et al., 2006) as well as interindividual focus (Burton et al., 2014; Ditzen et al., 
2008; Heinrichs et al., 2003; Kirschbaum et al., 1995; Robles, 2007) significantly attenuated 
cortisol stress responses in subjects completing the TSST. Those studies with interindividual 
perspectives that reported suppressed cortisol responses to the TSST included men receiving 
support from partners compared with unsupported and stranger-supported men (Kirschbaum et 
al., 1995) and individuals receiving support from family members although peer support was 
not associated with the neuroendocrine response (Burton et al., 2014). Noteworthy, next to the 
diminished cortisol response there were no significant differences in anxiety stress responses 
in men receiving support from the best friend (Heinrichs et al., 2003), from partner in compar-
ison to no social support (Ditzen et al., 2008) as well as in women with positive physical partner 
contact in comparison to verbal social support and no social interaction (Ditzen et al., 2007).   
Regarding cardiovascular parameters, a study with an interindividual focus revealed 
similar cardiovascular reactions in participants who received social support from a same-gender 
confederate before the TSST and no support in a healthy sample (Robles, 2007). Moreover, 
there were no significant differences in HR in women receiving support from a friend, a sup-
portive or neutral confederate during a speech (Christenfeld et al., 1997). In contrast, physical 
contact from the partner resulted in significantly reduced HR increase in response to the TSST 
while verbal social support was not associated with reduced HR stress responses in women 
(Ditzen et al., 2007). Although applying a different social stressor than the TSST but in line 
with our results, a group-based social support intervention showed no effects on cardiovascular 
stress responses and in contrast to our results, no effects on emotional stress responses (Anthony 
& O’Brien, 2002).  
The protocol of the TSST (Kirschbaum et al., 1993) could contribute to the explanation 
of our results of unaltered biological stress responses. The procedure of the TSST prevents any 
possibility to use or obtain social support in the stressful situation. The two confederates form-
ing the TSST committee are instructed to interact in a neutral way with the participants and not 
to give any positive verbal or non-verbal feedback or signs of communication other than that 
specified in the manual (Kirschbaum et al., 1993). Consequently, all efforts of participants to 
interact with the committee members in possible supportive ways are unsuccessful. Further-
more, otherwise stress-reducing social skills are not possible to be applied. Although not inves-
tigating a social support management, studies observing direct positive social interactions be-
fore or during a psychosocial stress test indicated a reduction of endocrine and cardiovascular 
reactivity to the stressor (Christenfeld et al., 1997; Ditzen et al., 2007; Kirschbaum et al., 1995; 
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Lepore, 1995; Uchino & Garvey, 1997).  
 
5.4. Limitations 
Study I (Publication I and II) has the following limitations: Only males were included as female 
menstrual cycle potentially could contribute to differences in HPA axis responses to psychoso-
cial stress (Kirschbaum, Kudielka, Gaab, Schommer, & Hellhammer, 1999). Furthermore, only 
healthy participants were included as medication intake could contribute as well to differences 
in HPA axis responses (Granger, Hibel, Fortunato, & Kapelewski, 2009). Considering the clin-
ical potential of Ze 185, future studies should include females as well as a clinical population 
with chronically stressed individuals or patients with stress-related disorders to establish the 
clinical value of Ze 185. It is important to note that the TSST is a laboratory stress setting. This 
allowed us to control some of the factors that are associated with changes in salivary cortisol 
secretion or in ANS parameters such as the consumption of caffeine (Lovallo, Farag, Vincent, 
Thomas, & Wilson, 2006) and alcohol (Zimmermann et al., 2004), smoking (Direk, Newson, 
Hofman, Kirschbaum, & Tiemeier, 2011), chewing (Scholey et al., 2009), high-intensity exer-
cise (Jacks, Sowash, Anning, Mcgloughlin, & Andres, 2002), and circadian rhythm of salivary 
cortisol secretion (Kudielka, Schommer, Hellhammer, & Kirschbaum, 2004). However, future 
studies should investigate stress occurring in more naturalistic settings closer to everyday life.  
 Study II (Publication III) has the following limitations: There was a significant differ-
ence in age between the two study group. In consequence, age was included as a control variable 
in all calculations. Furthermore, the sample size was rather small, limiting the statistical power 
of the study to detect small group differences. Also, only healthy women were included in the 
study. There is evidence for men also showing an increase in prosocial behavior during stress 
(von Dawans et al., 2012) which challenges the assumption that women are more likely to mo-
bilize social support when confronted with stress (Taylor et al., 2000). It is also important to 
note that the participants in our study reported high levels of perceived social support at base-
line. The TSST is a laboratory stress setting with explicitly no possibility applying positive 
social interactions. Furthermore, the completion of the TSST took place several weeks after the 
social support stress management (2-5 weeks). 
 
5.5. Conclusions and implications for future research 
Both the fixed herbal drug combination as well as the social support stress management atten-
uated the subjective emotional stress response the former in healthy men and the latter in 
healthy women, without altering the biological reactions in response to the standardized 
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psychosocial stress test. 
The results from Study I revealed that the fixed herbal drug combination significantly 
attenuated the self-reported state anxiety response in healthy men, without affecting the HPA 
axis and ANS stress responses. Given that a circumscribed biological stress response is to be 
considered as an adaptive mechanism, Ze 185 reduces state anxiety response without affecting 
assumingly adaptive biological stress responses to stress. In our study participants took a total 
of eleven film coated tablets over four days. Former studies demonstrating the effectiveness of 
Ze 185 used treatment doses of three tablets a day for up to ten days (Steiner & Opwis, 2000), 
20 days (Schellenberg et al., 2004), and 14 days with an onset of action on day 4 for anxiety 
symptoms (Melzer et al., 2009). Considering those results, future studies should observe the 
effects of longer treatment durations and dosages on the HPA axis and ANS stress responses. 
Additionally, future studies should include females as well as a clinical population with chron-
ically stressed individuals or patients with psychiatric disorders. Furthermore, although the 
TSST is to be considered a valid and effective stress test, future investigation should test the 
effects of Ze 185 on stress responses in naturalistic environments. The mechanisms through 
which Ze 185 affects the emotional stress responses are not yet understood. Future studies in-
cluding functional and structural neuroimaging could provide understanding on how Ze 185 
impacts emotional stress responses in humans. As such, stress-specific sustained increases in 
the amygdala, striatum, hypothalamus, midbrain, right insula, and right dorsolateral prefrontal 
cortex regions supported the stress processing and reactivity circuit (Sinha, Lacadie, Constable, 
& Seo, 2016). Considering medicinal plant extracts being part of Ze 185, several studies sug-
gested mechanisms mediated by the GABAA, 5-HT1A, and the adenosine A1 receptors (Becker 
et al., 2014; Bodesheim & Hölzl, 1997; Schumacher et al., 2002). Taking into account that Ze 
185 is a fixed herbal drug combination, its clinical efficacy can only be explained by a complex 
polypharmacological mechanism which still needs to be elucidated.  
Participants in our social support stress management did not differ in their cortisol, HR, 
and heart rate variability stress responses, albeit the intervention condition showed a signifi-
cantly attenuated integrated state anxiety response in comparison to the waitlist control condi-
tion. Considering the stress-buffering effect of the social stress management together with pre-
vious studies on social support, our results show the potential of social support in the context 
of dealing with stress (Ditzen et al., 2008). However, our results suggest that a testing situation 
with opportunities for positive interactions would be suitable in future studies to evaluate social 
stress management. Moreover, future research should include individuals reporting low levels 
of supportive social support as well as with clinical conditions. Furthermore, other stressors 
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closer to real life like measuring stress during exam periods could be appropriate way to reflect 
possible effects of the social support stress management. To boost a transfer into daily life it 
might be important to lengthen the duration of the intervention at a less intense rate and place 
higher emphasis on tasks which can be trained with friends and family in the intervals between 
the sessions. Although research has clearly shown that social support has a notable impact on 
morbidity and mortality, it rests fairly unclear how naturally occurring social support can be 
improved and if this is possible in a long-term way by training skills useful for receiving and 
offering social support. 
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Abstract 
Background: Considering the negative effects of stress on health, there is a growing interest in stress-
reducing interventions. The present study examines the effects of a fixed combination of valerian, pas-
sion flower, lemon balm, and butterbur extracts (Ze 185) on biological and affective responses to a 
standardized psychosocial stress paradigm. 
Purpose: The aim of the present study was to investigate the efficacy of Ze 185 on cortisol and anxiety 
stress responses to acute psychosocial stress in healthy subjects. 
Study Design: This study was a randomized, placebo-controlled, double blind study with 3 parallel 
groups. 
Methods: 72 healthy male participants were randomized to 3 groups Ze 185, placebo or no treatment 
during 4 days prior to a standardized psychosocial stress paradigm. Principle outcomes were salivary 
cortisol and self-reported anxiety responses to stress assessed at the fourth day.  
Results: The stress paradigm induced significant and large cortisol and self-reported anxiety responses. 
Groups did not differ significantly in their salivary cortisol response to stress, but participants in the 
Ze 185 condition showed significantly attenuated responses in self-reported anxiety in comparison to 
placebo (F(3, 41) = 3.33,  p = .03) and no treatment (F(3, 43) = 2.77, p = .05). 
Conclusion: The results show that Ze 185 significantly attenuated the subjective emotional stress re-
sponse during an acute stress situation, without affecting biological stress responses. Given that a cir-
cumscribed biological stress response is to be considered as an adaptive mechanism, Ze 185 reduces 
self-reported anxiety response to stress without affecting assumingly adaptive biological stress re-
sponses. 
 
Keywords: Valeriana officinalis, Passiflora incarnata, Petasites hybridus, Melissa officinalis, cortisol, 
anxiety   
  
Abbreviations:  
Adverse Event (AE), Area Under the Curve with respect to increase (AUCI) and ground (AUCG), Body 
Mass Index (BMI), Committee on Herbal Medicinal Products (HMPC), Drug Extract Ratio (DER), Eu-
ropean Pharmacopoeia (Ph. Eur.), Flame Ionization Detector (FID), Gamma-Aminobutyric acid 
(GABA), Gas Chromatography (GC), High Performance Liquid Chromatography (HPLC), Hypotha-
lamic-Pituitary-Adrenal (HPA), Intention To Treat (ITT), Per Protocol (PP), Standard Deviation (SD), 
State Anxiety of the State-Trait Anxiety Inventory (STAI-state), Trait anxiety of the State-Trait Anxiety 
Inventory (STAI-trait), Trier Social Stress Test (TSST) 
  
  
Introduction 
While physiological and psychological responses in the face of adversities are both functional and nec-
essary, biological, emotional as well as behavioral stress responses have been shown to negatively im-
pact on mental and physical health in the long term (McEwen, 2012). Thus, approaches to mitigate 
stress-related health impairments become a matter of public health. Here, several randomized-controlled 
trials have shown that stress management trainings significantly attenuated acute cortisol stress re-
sponses in healthy subjects (Hammerfald et al., 2006; Storch et al., 2007). Also, several pharmacological 
substances have been shown to attenuate saliva cortisol responses to acute stress in healthy participants 
such as benzodiazepine (Fries et al., 2006) and opioid agonists (Bershad et al., 2015).  
Considering the empirical status of herbal medicinal products for the treatment of stress and 
stress-reactivity, a number of randomized placebo-controlled trials indicate the potential of this ap-
proach in acute stress settings. In a randomized placebo-controlled study 600 mg of an extract combi-
nation of Melissa officinalis L. leafs and Valeriana officinalis L. roots reduced negative effects of the 
acute stress on ratings of anxiety in healthy individuals undergoing cognitive tasks (Kennedy et al., 
2006). Similarly, the fixed herbal drug combination Ze 185, containing extracts of Valeriana officinalis 
L. radix, Passiflora incarnata L. herba, Petasites hybridus (L.) P. Gaertn roots and Melissa officinalis 
L. folium, decreased anxiety levels in healthy participants in response to cognitive tasks in a random-
ized-placebo controlled study (Steiner and Opwis, 2000). Herbal preparations containing Passiflora in-
carnata L., Melissa officinalis L. as well as Valeriana officinalis L. have been traditionally used for the 
relief of mild symptoms of mental stress, assessed by the Committee on Herbal Medicinal Products 
(HMPC) of the European Medicines Agency (HMPC, 2013, 2014, 2016).  
However, data regarding the effects of the herbal extracts used in Ze 185 on psychophysiologi-
cal responses including the assessment of the activation of one of the major biological stress systems, 
namely the hypothalamic-pituitary-adrenal (HPA) axis with neuroendocrine cortisol stress responses, 
under acute psychosocial stress is missing. A previous study investigated physiological and psycholog-
ical stress responses in healthy participants completing cognitive tasks under the intake of Ze 185 and 
  
placebo (Steiner and Opwis, 2000). In other studies, the Ze 185 was investigated as treatment for psy-
chosomatic complaints in comparison of oxazepam (Schellenberg et al., 2004) and for somatoform dis-
orders (Melzer et al., 2009). The aim of the present study was therefore to investigate the efficacy of 
Ze 185, a fixed herbal drug combination, regarding neuroendocrine and psychological responses to 
acute psychosocial stress in healthy subjects. Considering the previous research with Ze 185 (Schellen-
berg et al., 2004; Steiner and Opwis, 2000; Melzer et al., 2009) we assume that Ze 185 will reduce the 
emotional responses to the stress tests, with possible attenuation of neuroendocrine responses in conse-
quence. 
 
Material and methods 
To observe the effects on neuroendocrine responses, the primary outcome was salivary cortisol secretion 
as the HPA axis is one of the major biological stress response systems. Previous research shows that the 
Trier Social Stress Test (TSST; see below; Kirschbaum et al., 1993) -protocol is a reliable tool to exper-
imentally evoke HPA axis stress responses (Allen et al., 2014). As secondary outcome, we chose self-
reported sate anxiety as a measure of psychological stress response. Furthermore, safety and compliance 
of Ze 185 and placebo were assessed with laboratory tests, physical examination, assessment of adverse 
events and drug accountability.  
 
Study medication 
Active ingredients of the herbal medicinal product Ze 185, a fixed herbal drug combination, were 90 
mg of a 90% (w/w) ethanolic extract of Petasites hybridus (L.) P. Gaertn., B. Mey. et Scherb. (Drug 
Extract Ratio; DER 7–14:1); 90 mg of a 45% (w/w) methanolic extract of Valeriana officinalis L. 
roots (DER 4–6:1); 90 mg of a 50% (w/w) ethanolic extract of Passiflora incarnata L. herb (DER 3–
6:1); 60 mg of a 20% (w/w) ethanolic extract of Melissa officinalis L. leaves (DER 2.5–3.9:1) per 
film-coated tablet. The extract has been registered in Switzerland since 1970. The herbal medicinal 
products containing Ze 185 are indicated for the following complaints: nervousness, tension, restless-
  
ness and exam nerves. These can lead to the following symptoms, amongst others: spasmodic gastro-
intestinal complaints, increased irritability and occasional trouble falling asleep and sleeping through 
the night. High performance liquid chromatography (HPLC) fingerprints of one extract batch of each 
extract of Ze 185 are shown in Fig. 1-4. For the study, the commercially available formulation of 
Zeller Entspannung film coated tablets was used. Placebo was identical in presentation, color, and 
shape. 
 
Participants 
85 participants were screened, of which 13 met one or more of the exclusion criteria. The remaining 72 
participants were randomized to namely Ze 185 (n = 24), placebo (n = 24), and no treatment (n = 24) 
groups (see Fig. 5). We included a no treatment group to be able to detect a possible placebo effect (i.e. 
difference between placebo and no treatment) in the placebo response (i.e. absolute effects of placebo 
administration). Inclusion criteria for the study were age between 18 and 45 years, male gender, and 
written informed consent. Previous research on the influence of age on cortisol responses is inconsistent 
(Agrigoroaei et al., 2013; Rohleder et al., 2002). However, Allen et al. (2014) point out the consideration 
that the testing environment of the standardized stress test (see below) itself might be more stressful for 
older participants compared to a younger population. Previous research has shown a broad moderating 
effect of gender on cortisol responses as well as has suggested a different behavioral stress response 
pattern in men and women (Allen et al., 2014; Taylor et al., 2000). Smoking, presence of somatic or 
psychiatric disorders, or any other clinically relevant diseases like hepatic, renal, cardiac respiratory 
disorders, alcohol or drug abuse, as well as previous participation in a TSST and in any psychotherapy 
were counted among the main exclusion criteria together with the use of defined concomitant medica-
tion. To check for exclusion criteria the screening procedures included anamnesis of medical and psy-
chiatric history and urinalysis for cotinine and drug use. All participants gave written informed consent.  
Randomized participants were financially compensated for their participation in the study. The study 
was approved by the local Ethics Committee and Swiss Agency for Therapeutic Products (Swissmedic, 
  
trial number: ZE185-4-2014-02) and registered on clinicaltrials.gov (ID: NCT02189239) and in the sup-
plementary federal database (Swiss National Clinical Trials Portal; ID: SNCTP000001075). The study 
followed the guidelines of the Declaration of Helsinki and Tokyo for humans. 
 
Procedure 
At the screening visit, electrocardiogram, physical examinations, blood samples for hematological and 
clinical chemistry parameters, and the vital signs were assessed for safety analyses and to detect any 
clinically relevant abnormalities. All those procedures were conducted by a physician, and his team at 
the University Hospital of Basel. Participants completed 3 visits (baseline: day 1, stress test: day 4, and 
end of study). At baseline (day 1) eligible participants were randomized to one of the study groups. 
Randomization was provided centrally with randomly permuted blocks of variable length with equal 
numbers of assignments to the 3 arms. The random code was supplied by an external provider using a 
validated random program. Participants were instructed to orally administer 3 film-coated tablets per 
day for the following 3 days, i.e. one tablet every morning, midday, and evening on days 1, 2 and 3. On 
day 4, all participants underwent a standardized psychosocial stress test. On this day, participants took 
2 film-coated tablets, i.e. in the morning and midday. The end of study visit was scheduled 3 to 5 days 
later and included a physical examination and laboratory tests. Adverse Events (AEs) were assessed 
throughout the study from giving informed consent signature until last visit and were evaluated by a 
medical doctor. 
 
Stress test 
On day 4 all participants were subjected to the TSST at the division of Psychology and Psychotherapy 
of the University Basel. The stress paradigm has repeatedly been found to induce profound psychobio-
logical stress responses in 70–80% of subjects (Kudielka et al., 2007). After 50 min upon arrival includ-
ing cortisol baseline assessment, participants were taken to the testing room and introduced to the TSST. 
The TSST procedure involves giving a free speech and a serially subtraction in front of a committee 
  
consisting of one male and one female as well as a video camera and microphone, both tasks lasting 5 
min each. Once completing the TSST further measurements for the next 90 min were assessed.  
Overall, 11 salivary cortisol samples were collected (-50, -35, -20, -10 min pre TSST and 0, 
10, 20, 30, 45, 60, 90 min post TSST; see Fig. 6). Saliva cortisol was collected using polypropylene 
saliva tubes (Sarstedt, Nümbrecht, Germany). Salivary free cortisol was assayed using the Salimetrics 
immunoassay method (EIA kits; Salimetrics LLC, USA). All samples were analyzed by the Swiss-
Analysis AG (Tägerwilen, Switzerland). The assay kits had an intra-assay variation of 3 to 7 % and 
inter-assay variation of 3 to 11%. The minimum detectable level of cortisol concentration was 0.007 
g/dl. 
  Subjective anxiety responses were assessed with the State-Trait Anxiety Inventory (STAI; Laux 
et al., 1981). The STAI-state part consists of 20 items rated on a 4-point scale with 1 = ”not at all” and 
4 = “very much” and has acceptable internal consistency and test-retest reliability (Lee et al., 2004). 
Participants completed the STAI-state before the TSST procedure (STAI-state 1; -45 min to TSST com-
pletion), right after completing the TSST (STAI-state 2), 30 min (STAI-state 3) as well as 90 min (STAI-
state 4) after the TSST in the recovery room (see Fig. 6). Furthermore, the STAI-state as well as STAI-
trait (Laux et al., 1981) were completed at day 1 for baseline assessment. At the end of study visit 
participants in the Ze 185 and placebo groups were asked by the study nurse about their assumption 
regarding which treatment they received. Their answers were noted.   
 
Statistical analysis 
The clinical trial data was collected in an electronic data capture system, named secuTrial®. An elec-
tronic case report form was implemented by the clinical trial unit at the University Hospital Basel. Anal-
yses were performed with the IBM SPSS version 21 statistical package. The shown analyses are based 
on the Intention to Treat (ITT) dataset. At the end of the study, one participant reported the intake of a 
medication defined as prohibited during participation of the study. Therefore, all analyses were 
additionally run on the Per Protocol (PP) dataset without this participant to exclude a possible bias of 
study results due to the concomitant medication. However, all analyses with the PP dataset led to similar 
  
results as with the ITT dataset (data not shown). Data were tested for normal distribution using Kolmo-
gorov–Smirnov test. Cortisol, STAI-state values, and baseline variables were log-transformed to ap-
proximate normal distribution. For better readability, the original values were used for Tables and Fig-
ures. Baseline characteristics of the study groups were compared with one-way analyses of variance or 
chi-square tests. Analysis of variance for repeated measures were computed to analyze cortisol and anx-
iety responses between the study groups. Additionally, area under the curve with respect to increase 
(AUCI) and area under the curve with respect to ground (AUCG) were calculated for cortisol data using 
the trapezoidal method (Pruessner et al., 2003). Post hoc analyses were examined with separate analyses 
of variance. According to the guidelines provided by Miller and colleagues (2013) we identified cortisol 
responders and non-responders. Non-responders were classified as cortisol baseline to peak increase 
lower than 1 nmol/l (Miller et al., 2013). Differences in the distribution of AEs in the study groups as 
well as accurate and incorrect treatment expectations between the Ze 185 and placebo groups were tested 
with separate chi-square tests. The endpoint used for the sample size estimation was cortisol AUCG. 
Sample size was estimated to be able to detect a difference in AUCG of 580 nmol/l between the groups 
treated with Ze 185 and placebo. Based on 0.8 power to detect a significant difference of this effect size 
and a 5 % significance level, 63 participants were required. In total 72 participants were enrolled con-
sidering an overall drop-out rate of 12%.  
  
Results 
Participants 
72 male healthy participants were randomly assigned to the Ze 185 group (n = 24), placebo group (n = 
24), and no treatment group (n = 24). 2 participants dropped out after randomization but before receiving 
study medication. The remaining 70 participants (ITT dataset) were between 18-44 years of age, had a 
mean body mass index (BMI) of 24.4 kg/m2 and the majority was Caucasian (see Table 1). The study 
groups did not differ with respect to any of the assessed demographic variables in age (F(2, 67) = 1.08, 
p = .35), BMI (F(2, 67) = 0.05, p = .96), distribution of ethnicity ( (4, N = 70) = 4.02, p = .40), state 
anxiety on day 1 (F(2, 67) = 0.09, p = .92), and trait anxiety on day 1 (F(2, 67) = 1.81, p = .17).  
 
Cortisol and affective stress responses 
The TSST induced significant and substantial increases in salivary cortisol levels (F(8, 60) = 40.28, p < 
.001). Our analyses revealed 10 participants classified as non-responders. Groups did not differ in the 
distribution of cortisol responders and non-responders ( (2, N = 70) = 0.27, p = .87). Cortisol levels 
among all participants did not differ between the 3 groups at baseline (F(2, 67) = 0.05, p = .95) and 
groups did not differ significantly in their cortisol responses over time (F(16, 122) = 0.43, p = .97) nor 
integrated cortisol responses (AUCI: F(2, 67) = 0.17, p = .84; AUCG: F(2, 67) = 0.002, p = .99; see Fig. 
7). 
Groups did not differ significantly in STAI-state baseline scores on day 4 (F(2, 67) = 0.50, p = 
.61) and the TSST resulted in a significant STAI-state response (F(3, 64) = 25.89, p < .001). Groups 
differed however significantly in the STAI-state response over time (F(6, 130) = 2.41, p = .03) and post 
hoc analyses revealed a significant time by group interaction effect between placebo and Ze 185 (F(3, 
41) = 3.33, p = .03), as well as between no treatment and Ze 185 (F(3, 43) = 2.77, p = .05) while response 
differences between no treatment and placebo were not significant (F(3, 42) = 1.42, p = .25; see Fig. 8).  
 
 
  
Adverse events 
In total, 11 participants (Ze 185 n = 3; placebo n = 5; no treatment n = 3) reported 16 non-serious AEs 
(Ze 185 n = 3; placebo n = 9; no treatment n = 4) with no differences in their distribution between groups 
( (2, n = 70) = 0.94, p = .63; n = 3 in Ze 185, n = 5 in placebo and n = 3 in no treatment group). All 
AEs were of mild intensity. 3 AEs in the Ze 185 group (headache, intermittent abdominal pain and 
flatulence) were recovered until the end of the study. The causality to the study medication was judged 
as possible by the physician according to World Health Organization criteria.  
 
Treatment expectation 
Groups significantly differed in correctly guessing drug assignment ( (1, N = 45) = 10.02, p = .002), 
with more accurate ratings in the placebo group than in the Ze 185 group (in the Ze 185 group: 36.4% 
"verum group", 63.3% "placebo group"; in the placebo group: 17.4% "verum group", 82.6% "placebo 
group").  
 
Drug adherence 
One participant in the Ze 185 group took one tablet too much and thus self-administered 12 instead of 
11 film coated tablets of Ze 185. Drug intake of all participants completing the TSST was within the 
predefined range of 80-120% (9-13 tablets).   
  
Discussion 
The present double-blind randomized placebo-controlled study investigated the effect of the herbal me-
dicinal product Ze 185 on cortisol and self-reported state anxiety stress responses to acute experimen-
tally induced stress in healthy men.  
In comparison to placebo and no treatment, participants receiving Ze 185 showed significantly 
attenuated subjective anxiety response to stress, marked by a lower response as well as a more rapid 
recovery in comparison to placebo or no treatment. Groups did not differ significantly in salivary cortisol 
stress responses. Ze 185 was safe and well tolerated. No serious AEs and only 3 non-serious AEs were 
reported in the Ze 185 group. Noteworthy, nearly two-third of participants in the Ze 185 group assumed 
they were randomized to the placebo group, while over 80% of participants in the placebo condition 
correctly presumed to have received placebo. Groups did not differ in the distribution of cortisol re-
sponders and non-responders and also, the rate of responders goes in line with previous reported re-
sponse rates (Kudielka et al., 2007). 
In line with our results, several randomized placebo-controlled trials investigating herbal me-
dicinal interventions (e.g. Kennedy et al., 2006; Lee et al., 2004) have reported decreased levels of 
anxiety in healthy subjects undergoing cognitive tasks (Kennedy et al., 2006) and an academic exami-
nation (Lee et al., 2004). Thus and also in line with previous studies with Ze 185 (Melzer et al., 2009; 
Schellenberg et al., 2004; Steiner and Opwis, 2000), specific herbal medicinal interventions appear to 
be effective in reducing subjective anxiety and anxiety responses to acute stress. Although the mecha-
nism of action of Ze 185 is not fully understood, for valerian, passion flower and lemon balm anxiolytic 
effects have been suggested in several preclinical studies. The modulation of the Gamma-Aminobutyric 
acid (GABA)A receptor provides a plausible mechanism for certain constituents from valerian (e.g. 
valerenic acid; Becker et al., 2014). Further, a glutamatergic mechanism has been suggested (Del Valle-
Mojica et al., 2011). In addition, the lignans 8-hydroxypinoresinol and other olivil derivatives have been 
shown to potently bind to 5-HT1A or adenosine A1 receptors, both representing pharmacological targets 
mediating anxiolytic effects (Bodesheim and Hölzl, 1997; Schumacher et al., 2002). As for passion 
flower and lemon balm, anxiolytic effects have been proposed to be mediated also via the GABAergic 
  
system (Grundmann et al., 2008; Ibarra et al., 2010). 
Similar to our results, a number of trials reported a dissociation of subjective and objective 
stress responses, i.e. reduced anxiety responses in face of unaltered cortisol responses (e.g. mindfulness 
meditation: Creswell et al., 2014). Noteworthy, the adaptive function of increased cortisol levels has 
recently received new support. For example, higher cortisol responses in the TSST are associated with 
fewer errors in threat-related decision making in police officers (Akinola and Mendes, 2012). Thus, 
there is reason to assume an important functionality of cortisol stress responses, which may serve to 
support positive and/or protect against negative emotional responses.  
The present study has the following limitations. Only healthy males were included as female 
menstrual cycle stress potentially could contribute to differences in HPA axis responses to psychosocial 
stress. Considering the clinical potential of Ze 185, future studies should include females as well as a 
clinical population with chronically stressed individuals or patients with psychiatric disorders. In this 
regard, it is important to note that we assessed anxiety response to experimentally induced acute psy-
chosocial stress, which should not be equated to clinical conditions. Additionally, as we observed short 
term outcome of acute stress, we want to emphasize that we do not suggest adaptogenic effects. Fur-
thermore, although the TSST is to be considered a valid and effective stress test, future investigation 
should test the effects of Ze 185 on stress responses in naturalistic environments. We controlled several 
factors that are associated with changes in salivary cortisol secretion such as circadian rhythm, the con-
sumption of alcohol, smoking, chewing and high-intensity exercise (Kudielka et al., 2007). In our study 
participants took a total of 11 film coated tablets over 4 days. In previous studies demonstrating the 
effectiveness of Ze 185 the medication was taken 3 times a day for up to 10 days (Steiner and Opwis, 
2000), 20 days (Schellenberg et al., 2004), and 14 days with an onset of action on day 4 for anxiety 
(Melzer et al., 2009).  
The mechanisms through which Ze 185 affects the emotional stress responses are not yet un-
derstood. Future studies including functional and structural neuroimaging could provide understanding 
on how Ze 185 impacts affective stress responses in humans. As such, specific patterns of neural acti-
vation in brain circuits underlying a stress response have been demonstrated. Stress-specific sustained 
  
increases in the amygdala, striatum, hypothalamus, midbrain, right insula, and right dorsolateral pre-
frontal cortex regions supported the stress processing and reactivity circuit (Sinha et al., 2016). Several 
studies investigating separately the medicinal plant extracts being part of Ze 185 suggest mechanisms 
mediated by the GABAA, 5-HT1A and the adenosine A1 receptors (Becker et al., 2014; Bodesheim and 
Hölzl, 1997; Schumacher et al., 2002). As Ze 185 is a fixed herbal drug combination its clinical efficacy 
can only be explained by a complex polypharmacological mechanism which still needs to be elucidated. 
In summary, our results show that Ze 185 significantly attenuates the subjective emotional 
stress response during acute stress situation in healthy men, without affecting physiological parameters. 
Given that a circumscribed biological stress response is to be considered as an adaptive mechanism, the 
attenuation of the subjective anxiety response may reflect the possibility of Ze 185 being an effective 
intervention to reduce subjective stress while maintaining the adaptive biological stress responses. How-
ever, the underlying mechanisms leading to decreased subjective anxiety levels remain unclear. Further 
research is needed to elucidate the mechanisms of action of Ze 185 with regard to emotional stress re-
sponses.  
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Table and Figure legends 
 
Table 1 
Group means (SD) and distribution for demographics characteristics at baseline (n = 70; ITT-dataset). 
 
 
 
 
 
 
 
 
  
Fig. 1. HPLC fingerprint of valerian dry extract batch 140218 performed with reversed phase HPLC 
(HPLC 1100 Series Agilent); stationary phase: C-18 column (5 µm); mobile phase: gradient using ace-
tonitrile and 5 g/ l solution of phosphoric acid in water; ultraviolet-detection at 220 nm (according to 
Ph. Eur. 8, 07/2014:1897). 
 
 
Fig. 2 . HPLC fingerprint of melissa dry extract batch 121283 performed with reversed phase HPLC 
(HPLC 1100 series Agilent); stationary phase: C-18 column (5 µm); mobile phase: gradient using (A) 
phosphoric acid, acetonitrile, water (1:19:80 V/V/V) and (B) phosphoric acid, methanol, acetonitrile 
(1:40:59 V/V/V); ultraviolet-detection at 330 nm (according to Ph. Eur. 6, 01/2010:2524). 
 
 
	
  
Fig. 3. HPLC fingerprint of passion flower dry extract batch 130810 performed with reversed phase 
HPLC (HPLC 1100 series Agilent); stationary phase: C-18 column (3 µm) containing a C-18 pre-col-
umn; mobile phase: gradient using 0.05 M phosphoric acid in water and acetonitrile; ultraviolet-detec-
tion at 336 nm. 
 
 
Fig. 4. GC fingerprint in petasites root dry extract batch 131661 performed with gas chromatography 
(GC Agilent 6890N Series); stationary phase: DB-1 column (25 m, Ø 0.32 mm, 0.52 µm); mobile 
phase: hydrogen gas; gradient: temperature gradient from 180 °C to 300 °C; detection: FID. 
 
 
 
 
	
	
  
Fig. 5. Flow chart of participants from initial assessment for eligibility sample to salivary cortisol ana-
lytic sample. 
 
 
Fig. 6. Study design of day 4 with state anxiety of the State-Trait Anxiety Inventory (STAI-state) as 
well as saliva measuring points in relation to time to completion of the Trier Social Stress Test (TSST). 
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Fig. 7. Absolute salivary cortisol responses (mean/standard error of the mean) of the 3 study groups in 
the Trier Social Stress Test (TSST) at day 4. Intro = introduction to the TSST. 
 
 
Fig. 8. Absolute state anxiety of the State-Trait Anxiety Inventory (STAI-state) responses (mean/stand-
ard error of the mean) of the 3 study groups in the Trier Social Stress Test (TSST) at day 4.
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 Abstract 
Background and Objectives: Stress-related dysregulation of the autonomic nervous system 
has been shown to be associated with disease processes and clinical outcomes. As we 
previously reported a significant reduction of anxiety responses in face of normal cortisol stress 
responses in healthy men undergoing a standardized psychosocial stressor and on treatment 
with Ze 185, a fixed herbal drug combination, we here set out to assess whether Ze 185 has an 
effect on autonomic nervous system responses to acute psychosocial stress. 
Design: A randomized, placebo-controlled, double blind study with three parallel groups. 
Seventy-two healthy men were randomly assigned to three groups receiving Ze 185, placebo, 
or no treatment. 
Methods: Participants underwent a standardized psychosocial stress test while heart rate, heart 
rate variability, salivary alpha-amylase, skin conductance level and skin temperature were 
repeatedly assessed. The study was approved by the local Ethics Committee and Swiss Agency 
for Therapeutic Products (Swissmedic, trial number: ZE185-4-2014-02) and registered on 
clinicaltrials.gov (ID: NCT02189239) and in the supplementary federal database (Swiss 
National Clinical Trials Portal; ID: SNCTP000001075). 
Results: Significant stress responses (all p<.05) were evident on all physiological parameters. 
The stress responses of any of the assessed physiological parameters between the three study 
groups did not differ significantly (all p>.05).  
Conclusion: Our results indicate that autonomic nervous system stress responses remained 
unaffected by Ze 185, while it attenuated subjective anxiety responses (as previously reported). 
In line with the previous findings, Ze 185 attenuates the affective stress response without 
affecting the physiological stress response.  
 Introduction 
Stress has been shown to induce activity alterations of the autonomic nervous system (ANS; 
(Allen, Kennedy, Cryan, Dinan, & Clarke, 2014). Stress and stress-related dysregulations of 
ANS activity have been shown to be associated with disease processes and clinical outcome 
(Booth et al., 2015; Suh et al., 2013; Xhyheri, Manfrini, Mazzolini, Pizzi, & Bugiardini, 2012). 
Clinical trials addressing autonomic dysfunctions indicate benefits of beta-blockers, at least in 
part due to heart rate lowering (Caetano & Alves, 2015; London, 2008). However, the use of 
beta-blockers is a controversially discussed as e.g. beta-blockers increased risk for new-onset 
diabetes in patients with hypertension (Bangalore, Parkar, Grossman, & Messerli, 2007; 
Caetano & Alves, 2015; London, 2008). To counter or prevent stress-associated detrimental 
ANS processes, several studies also examined the effects of non-pharmacological interventions 
on ANS parameters and functioning in healthy subjects. Here, randomized-controlled trials 
have shown a buffering effect on the ANS stress response. For example, cardiovascular stress 
responses to psychosocial stress was dampened in subjects undergoing psychological and 
behavioral interventions (Kemeny et al., 2012; Klaperski, von Dawans, Heinrichs, & Fuchs, 
2014) and cardiovascular as well as salivary alpha-amylase (sAA) stress reactivity were 
diminished in subjects participating in a self-compassion intervention (Arch et al., 2014). 
Furthermore, physical partner contact prior to acute stress led to reduced heart rate responses 
(Ditzen et al., 2007) and listening to relaxing music resulted in a faster sAA recovery after 
stress (Thoma et al., 2013).  
Herbal preparations containing Passiflora incarnata L., Melissa officinalis L. as well 
as Valeriana officinalis L. have been traditionally used for the relief of mild symptoms of 
mental stress, assessed by the Committee on Herbal Medicinal Products (HMPC) of the 
European Medicines Agency (HMPC, 2013, 2014, 2016). Reduced stress-related symptoms 
(e.g. anxiety manifestations, insomnia, psychosomatic symptoms) were found in participants 
with anxiety disorder taking capsules with a standardized, hydroalcoholic Melissa officinalis 
L. leaf extract with the 600 mg dose of the combination (300 mg; Cases, Ibarra, Feuillere, 
Roller, & Sukkar, 2011) and better stress resistance was experienced after 12 weeks of 
treatment with Passiflora incarnate L. in patients with nervous restlessness (424 mg, 
drug/extract ratio 5:1-7:1, extraction solvent: ethanol 50%; Gibbert, Kreimendahl, Lebert, 
Rychlik, & Trompetter, 2017). With regard to stress reactivity, randomized placebo-controlled 
trials reported promising results. A fixed herbal drug combination of Valeriana officinalis L. 
radix, Passiflora incarnata L. herba, Petasites hybridus (L.) P. Gaertn roots and Melissa 
officinalis L. folium decreased electro dermal activity in patients with psychosomatic 
 complaints (Schellenberg, Sauer, & Brattström, 2004). A randomized-controlled study found 
reduced heart rate responses in participants taking tablets of valerian (LI 156, Sedonium, 
containing 300mg ethanolic dried valerian root extract, drug/extract ratio 3-6:1; Cropley, Cave, 
Ellis, & Middleton, 2002).  
However, researchers in the field of herbal medicinal products have made limited use 
of ANS stress indicators under rigorously controlled conditions. We therefore set out to assess 
the effects of the fixed herbal drug combination Ze 185 on several ANS biomarkers in healthy 
men undergoing a standardized psychosocial stressor in a three-armed trial including placebo 
and no treatment. In a first publication, we reported results of cortisol and anxiety stress 
responses (Meier et al., 2018), here we report the stress responses of the secondary outcomes.  
 
 
Methods 
Participants 
Healthy non-smoking men between the age of 18 and 45 years were invited to the University 
Hospital Basel to attend a screening procedure to test study eligibility. Participants were 
recruited at the division of Clinical Pharmacology and Toxicology of the University Hospital 
Basel using a recruitment notice on the Internet platform of the University of Basel. After the 
participants were provided with complete written and oral description of the study, written 
informed consent was obtained. Throughout this study, all data was identified only by an 
identification number to guarantee anonymity of the participants. The screening procedures 
included laboratory and urinalysis for cotinine and drug tests, an electrocardiogram, physical 
examinations and the check of vital signs. Individuals with previous participation in the 
employed psychosocial stress paradigm (see below), undergoing psychotherapy, and who had 
participated in another clinical trial in the preceding four weeks were excluded. A total of 85 
participants were screened, of which 13 met one or more of the exclusion criteria. The 
remaining 72 participants were randomized to Ze 185 (n=24), placebo (n=24), and no treatment 
(n=24) groups. 
 
Procedures 
After the screening visit the participants completed three visits (baseline, stress test, and end 
of study). At baseline, participants completed the baseline questionnaires for assessing state 
and trait anxiety with the State-Trait Anxiety Inventory (STAI-state and STAI-trait; 
Spielberger, Laux, Glanzmann, & Schaffner, 1981). Randomization was delivered centrally 
 with randomly permuted blocks of variable length with equal numbers of assignments to the 
three arms, and the random code was supplied by an external provider using a validated random 
program. Participants in the Ze 185 and the placebo group received film coated tablets. Active 
ingredients of Ze 185 were 90 mg of an ethanolic extract of Petasites hybridus (L.) P. Gaertn. 
Roots, 90 mg of a methanolic extract of Valeriana officinalis L. roots, 90 mg of an ethanolic 
extract of Passiflora incarnata L. herb, and 60 mg of an ethanolic extract of Melissa 
officinalis L. leaves per film-coated tablet. Placebo was identical in presentation, color and 
shape. Participants were instructed to orally administer three film-coated tablets per day: one 
tablet every morning, midday, and evening for three days. On day 4, participants took one film-
coated tablet in the morning and one at midday before undergoing a standardized psychosocial 
stress test (Trier Social Stress Test; TSST; see below; Kirschbaum, Pirke, & Hellhammer, 
1993). During this stress examination, eleven saliva samples were collected (-50, -35, -20, -10 
minutes pre TSST, and 0, 10, 20, 30, 45, 60, 90 minutes post TSST). All ANS parameters were 
assessed with the wireless physiological recording system BioNomadix® (Biopac Systems, 
Inc., Santa Barbara, CA 93117). For each parameter, 5-minute intervals were measured at 
seven time points: baseline (-35 minutes before TSST completion), preparation directly after 
the TSST introduction (-17 minutes before TSST completion), TSST speech (first half of the 
TSST), TSST arithmetic task (second half of the TSST), recovery 1 (5-10 minutes after TSST 
completion), recovery 2 (20-25 minutes after TSST completion), and recovery 3 (25-30 
minutes after TSST completion). The end of study visit was scheduled 3 to 5 days later to 
conduct physical examination and laboratory tests. Adverse events were recorded throughout 
the study.  
 
Stress test 
On day 4, all participants underwent the TSST (Kirschbaum et al., 1993), a psychosocial stress 
test, considered as the gold standard test to induce reliable psychobiological stress responses 
(Bali & Jaggi, 2015). Participants were instructed not to undergo excessive physical activity 
for 24 hours prior to the visit, not to consume caffeine and alcohol for 12 hours prior to the 
visit as well as not to eat a major meal and drink anything other than water 60 minutes prior to 
the visit. Stress tests were scheduled on Mondays or Fridays in the afternoon, with the stress 
test starting between 2pm and 4:30pm. Upon arrival at day 4 at the division of Clinical 
Psychology and Psychotherapy of the University Basel, participants were seated in a quiet 
room for instructions. After 30 minutes, which included a saliva baseline assessment, 
participants were taken to the testing room and introduced to the TSST. A fake selection 
 committee consisting of one male and one female were already sitting at a table with a video 
camera and a laptop cable-connected to a microphone visible for the participants in the testing 
room. The TSST was briefly explained to participants, which were then guided back to the first 
room for the preparation phase. After preparing for the TSST the participants were guided to 
the testing room to give a free speech in front of the committee during the next 5 minutes. 
Then, the participants were asked to conduct a serial subtraction for the next 5 minutes. In case 
of failure, subjects were instructed to restart. After the TSST exposure, participants were 
guided into a third room for further measurements over the next 90 minutes.  
 
Measures 
Saliva samples: salivary alpha-amylase 
The sympathetic nervous system activity can be tracked using the enzyme sAA (Allen et al., 
2014). Several studies clearly show that sAA increases in states of stress or arousal (Grisham, 
King, Makkar, & Felmingham, 2015; Nater & Rohleder, 2009). Saliva samples were stored at 
-20 °C until analysis. Frozen saliva samples will precipitate mucins. Completely defrosted 
saliva samples were vortexed and subsequently centrifuged at 1500 x g (3000rpm) for 15 
minutes.  The centrifuged saliva samples were diluted 1:200 by first diluting samples 1:10 with 
the alpha-amylase diluent provided followed by a 1:20 dilution of the 1:10 diluent sample 
resulting in a final dilution of 1:200. The Salimetrics® α-Amylase Kinetic Enzyme Assay Kit 
is specifically designed and validated for the kinetic measurement of sAA activity. The 
principle of this enzymatic test is based on a chromagenic, 2-chloro-p-nitrophenol linked with 
maltotriose. The enzymatic action of alpha-amylase on this substrate yields 2-chloro-p-
nitrophenol, which can be spectrophotochemically measured at 405 nm. The amount of alpha-
amylase activity (U/ml) present in the sample is directly proportional to the increase in 
absorbance at 405 nm. All reagents and kit components were prepared according to the 
manufacturer´s instructions. Plate reader and heater were set to incubate at 37°C. Intra- and 
inter-assay coefficients of variation were less than 7.3%. and 5.9%, respectively. All samples 
were analyzed by Swiss-Analysis AG (Tägerwilen, Switzerland). 
 
Electrophysiological measures 
Electrocardiographic activity was continuously recorded at 1000 Hz with three disposable, pre-
gelled Ag/AgCI electrodes attached to the skin at the beginning of the visit with the 
BioNomadix® system of wearable wireless devices (Biopac Systems Inc.). The ECG data was 
filtered with a FIR bandpass filter from 0.5 Hz to 35 Hz with 8000 Coefficients with the 
 AcqKnowlege® software (Biopac Systems Inc.). All data were visually inspected and artifacts 
edited by linear interpolation. After data collection, heart rate (HR) and heart rate variability 
(HRV) parameters were derived with the VivoSense® software (VivoNoetics, US). For HRV, 
a time domain measure, namely the square root of the mean of the sum of the squares of 
differences between adjacent normal-to-normal intervals (RMSSD), was determined. This 
parameter is one of the most commonly used measures derived from interval differences (Task 
Force of the European Society of Cardiology, 1996) and indicates the activity of the vagus 
nerve.  
 Two electrodes pre-gelled with isotonic gel and Ag/AgCl contact (EL507, Biopac Inc.) 
were placed at the volar surfaces of distal phalanges of two fingers of the non-dominant hand 
to record electro dermal activity (EDA). The volar phalanges of the fingers show greater 
responsivity and seat gland activity than other spots of the hand (Boucsein et al., 2012). EDA 
was continuously recorded at 500 Hz with the BioNomadix® system (Biopac, Inc.). The EDA 
data was filtered with a FIR low pass filter of 1 Hz with the AcqKnowledge® software (Biopac 
Systems Inc.). The same 5-minute intervals as for the ECG data were chosen to build the EDA 
intervals (baseline, preparation, TSST 1, TSST 2, recovery 1, recovery 2, and recovery 3). All 
data were visually inspected and artifacts edited by linear interpolation. To investigate EDA, 
skin conductance level (SCL) was obtained with the AcqKnowledge System (Biopac, Inc.). 
SCL is a measure of the long-term tonic state of electro dermal activity of the skin. SCL is 
widely used as index of sympathetic nervous system arousal (Boucsein et al., 2012).  
 Skin surface temperature was continuously recorded at 500 Hz with the BioNomadix® 
system. The stainless-steel banjo sensor was attached on the volar surfaces of distal phalanges 
of the middle finger of the non-dominant hand. The skin temperature (SKT) data was 
resampled to 15.625 samples per second with the AcqKnowledge software (Biopac Systems 
Inc). All data were visually inspected and artifacts edited by linear interpolation. With the 
AcqKnowledge® software, the mean values of SKT for the intervals were obtained (Biopac 
Systems Inc).  
 
Data analyses 
The clinical trial data was collected in the electronic data capture system secuTrial®. The 
electronic case report form was implemented by the clinical trial unit at the University Hospital 
Basel. Statistical analyses were performed with the IBM SPSS version 21 statistical package. 
The shown analyses are based on the Intention to Treat (ITT) dataset. Since one participant in 
the placebo group was excluded due to medication defined as exclusion criteria, all analyses 
 were also run on the Per Protocol (PP) dataset. However, all analyses with the PP dataset led 
to similar results as with the ITT dataset (data not shown). Data were tested for normal 
distribution using Shapiro-Wilk test. sAA variables were square-root-transformed and HR, 
RMSSD, SCL, and SKT variables were log transformed to approximate normal distribution. 
For better readability, the original values were used for Figures. Baseline characteristics of the 
study groups were compared with one-way analyses of variance or chi-square tests. Analysis 
of variance for repeated measures were computed to compare sAA, HR, RMSSD, SCL, and 
SKT data between the three study groups. For effect sizes, partial eta2 were reported, where 
appropriate, according to the following conventions: 0.01=small, 0.06=medium, 0.13=large 
(Cohen, 1988). With regard to electrophysiological measures, artifacts, loosening electrodes 
and technical problems resulted in a loss of data from single subjects, resulting in different n. 
 
 
Results 
Participants 
Seventy-two male healthy participants were randomly assigned to the Ze 185 group (n=24), 
placebo group (n=24), and no treatment group (n=24). Two participants dropped out after 
randomization, but before receiving study medication (see Figure 1). The remaining 70 
participants (ITT dataset) were between 18-44 years of age (M=26.07, SD=5.17 years), had a 
mean body mass index (BMI) of 24.4 kg/m2 and the majority was Caucasian. The study groups 
did not differ with respect to any of the assessed demographic variables, i.e. age (F(2, 67)=1.08, 
p=.35), BMI (F(2, 67)=0.05, p=.96), distribution of ethnicity (c2(4, N=70)=4.02, p=.40), state 
anxiety on day 1 (F(2, 67)=0.09, p=.92), and trait anxiety on day 1 (F(2, 67)=1.81, p=.17).  
 
Salivary alpha-amylase  
The TSST induced a significant increase in sAA levels (F(8, 60)=28.17, p<.001, partial eta2= 
.79). sAA levels did not differ between the three groups (Ze 185 n=23, placebo n=23, no 
treatment n=24) at baseline (F(2, 67)=0.05, p=.95) as well as over time (F(16, 122)=0.95, 
p=.51; see Figure 2).  
 
Cardiovascular stress responses 
The TSST induced significant and substantial increases in HR levels (F(6, 47)=55.17, p<.001, 
partial eta2= .88). HR levels did not differ between the three groups (Ze 185 n=17, placebo 
 n=18, no treatment n=20) at baseline (F(2, 52)=2.26, p=.11) as well as over time (F(12, 
96)=1.42, p=.17; see Figure 3).  
The TSST induced significant and substantial decreases in RMSSD levels (F(6, 
47)=6.95, p<.001, partial eta2= .47). RMSSD levels did not differ between the three groups (Ze 
185 n=17, placebo n=18, no treatment n=20) at baseline (F(2, 52)=0.54, p=.58) as well as over 
time (F(12, 96)=0.90, p=.56).  
 
Skin conductance level 
The TSST induced significant and substantial changes in SCL (F(6, 44)=27.64, p<.001, partial 
eta2=.79). SCL did not differ between the three groups (Ze 185 n=20, placebo n=14, no 
treatment n=18) at baseline (F(2, 49)=0.54, p=.59) as well as over time (F(12, 90)=1.39, 
p=.18).  
 
Skin temperature 
The TSST induced significant changes shown as decreases in SKT (F(6, 57)=104.74, p<.001, 
partial eta2=0.92). The SKT did not differ between the three groups at baseline (F(2, 65)=0.87, 
p=0.42). There were no significant time by group interaction effects (F(12, 116)=0.80, p=0.65). 
 
 
Discussion 
The aim of the present work was to compare the effects of the fixed herbal drug Ze 185 and 
placebo on ANS stress responses compared to a no treatment group in participants undergoing 
an acute psychosocial stress situation. All participants experienced significant and strong stress 
responses, but there were no significant differences in sAA, HR, HRV, SCL, and SKT stress 
responses between the three conditions.  
Several studies aimed at investigating the effects of herbal products as used in the 
current study (i.e. valerian, passion flower, butterbur, lemon balm) in the context of stress. 
Although these studies were not without promise, i.e. reporting reduced stress-related 
symptoms in participants with anxiety disorder taking capsules with Melissa officinalis L. leaf 
extract with the 600 mg dose of the combination (300 mg; Cases et al., 2011) or better stress 
resistance after 12 weeks of treatment with a standardized extract of Passiflora incarnate L. in 
patients with nervous restlessness (424 mg, drug/extract ratio 5:1-7:1, extraction solvent: 
ethanol 50%; Gibbert et al., 2017), studies examining the effects of herbal products on 
cardiovascular parameters produced mixed results and thus were less convincing. One 
 randomized placebo controlled study examining HR in response to a dentist surgery found no 
significant differences between participants taking either 100 mg valerian or placebo capsules 
(Pinheiro, Alcântara, de Moraes, & de Andrade, 2014), while another randomized controlled 
study found declined HR responses within subjects in response to a mental stress task after 
taking 2 times daily 300 mg tablets containing valerian (LI 156, Sedonium, containing 300 mg 
ethanolic dried valerian root extract, drug/extract ratio 3-6:1; Cropley et al., 2002). 
Nevertheless, the comparison to our results is limited as none of the studies induced acute 
psychosocial stress in a laboratory setting and only one of the mentioned studies included a 
placebo group (Pinheiro et al., 2014), while others did not encompass any comparison group 
(Cases et al., 2011; Gibbert et al., 2017). 
In line with our results, other studies found an increase in sAA in participants being 
confronted to the TSST (Allen et al., 2014; Het, Schoofs, Rohleder, & Wolf, 2012). Although 
sAA is a popular and promising biomarker of ANS in stress research in the context of 
psychological approaches (e.g. Thoma et al., 2013) as well as synthetically drugs (e.g. van Veen 
et al., 2009), previous studies on herbal medicine mainly focused on hypothalamic-pituitary-
adrenal activity (e.g. al'Absi et al., 2013; Lee, Park, & Moon, 2004).  
The participants in our study experienced a decrease in distal SKT in response to the 
acute stress. This stress response in SKT is in line with a study applying the TSST which found 
reduced SKT measured at fingertips (Vinkers et al., 2013). Changes in SKT are mediated by 
the sympathetic nervous system. A decrease in diameter in the peripheral blood vessels and, as 
a consequence, decreased blood flow results in reduced SKT (Ahmed, Begum, Funk, Xiong, 
& von Scheele, 2011). SKT is often used in biofeedback techniques as a simple way of 
identifying stress changes (Karthikeyan, Murugappan, & Yaacob, 2012). However, it is 
important to note that SKT measurement may not perfectly reflect peripheral vasomotion as 
this parameter may be affected by factors as evaporation, muscle tone, and core temperature 
(Shusterman & Barnea, 2005). 
We have previously reported that Ze 185 (Meier et al., 2018) led to a reduced anxiety 
response to acute psychosocial stress, with no effect on the cortisol stress response. In line with 
these findings, stress responses of the parameters of the ANS remained unaffected by the 
administration of Ze 185. Whether this is a result of the used dosage or duration of treatment 
can only be speculated and needs to be addressed by future studies. Previous studies with Ze 
185 used longer treatment periods of 20 days (Schellenberg et al., 2004), two weeks (Melzer, 
Schrader, Brattström, Schellenberg, & Saller, 2009), and up to 10 days (Steiner & Opwis, 
2000).  
 Although the mechanism of action of Ze 185 is not fully understood, the effects of valerian as 
well as lemon balm have been shown to be mediated through modulation of GABA receptors 
(Awad, Muhammad, Durst, Trudeau, & Arnason, 2009; Becker, Felgentreff, Schröder, Meier, 
& Brattström, 2014; Ibarra, Feuillere, Roller, Lesburgere, & Beracochea, 2010). The potential 
mechanisms through which Ze 185 could affect ANS stress responses are yet to be elaborated. 
As such, specific patterns of neural activation in brain circuits underlying a stress response 
have been demonstrated, such as the amygdala, striatum, hypothalamus, midbrain, right insula, 
and right dorsolateral prefrontal cortex regions (Sinha, Lacadie, Constable, & Seo, 2016). Our 
results are based on a laboratory setting applying a standardized stress test with healthy men. 
Future studies should as well include female participants to investigate possible gender effects. 
Also, it would be interesting to investigate real-life stressors over a longer period (e.g. 
examination phase) rather than experimentally induced acute psychosocial stress. Furthermore, 
the physiological effects of Ze 185 in clinical populations should be taken into account. Hereby, 
the investigation of patients with stress-related clinical conditions would be especially 
interesting.  
In summary, our results show that the stress responses of the ANS parameters i.e. sAA, 
HR, HRV, SCL, and SKT, remained unaffected of Ze 185 in healthy men compared to placebo 
and no treatment. This finding goes in line with previous reported cortisol stress responses 
(Meier et al., 2018). Taken these findings together, the responses of the two major biological 
stress systems namely the hypothalamic-pituitary-adrenal axis and the ANS are maintained 
under the intake of Ze 185 while subjective anxiety is reduced. Given that a circumscribed 
biological stress response is to be considered as an adaptive mechanism and considering the 
effects on subjective affective parameters (e.g., Cases et al., 2011; Melzer et al., 2009; 
Schellenberg et al., 2004; Steiner & Opwis, 2000) next to the high acceptability and low risks 
(Lynch & Berry, 2007), further studies on the effects of herbal medicinal products are 
warranted to understand who might benefit from these products and for which conditions.  
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 Figure 1. Flow chart of participants from initial assessment for eligibility sample to  
TSST completion sample. 
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Figure 2. Changes in salivary alpha-amylase over time by groups.  
Note: Intro= Introduction to the TTST, TSST= Trier Social Stress Test. 
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Figure 3. Changes in heart rate over time by groups in beats per minute.  
Note: Intro= Introduction to the TTST, TSST= Trier Social Stress Test. 
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 Abstract 
Background and Objectives: Enduring exposure to stress has a negative impact on mental and 
somatic health. Considering the high and increasing prevalence of stress, approaches to mitigate 
stress-related symptomatic as well as physiological consequences become a matter of public 
health. Since supportive social interactions contribute substantially to mental and physical 
health, we set out to develop and evaluate a social support stress management intervention in 
healthy women.  
Methods: In total, 52 healthy women were randomly assigned to a social support stress 
management or a waitlist control condition. All participants completed self-report question-
naires of perceived stress and social support at baseline and follow-up eight weeks later. Also, 
all participants underwent a standardized psychosocial stress test where physiological and emo-
tional stress responses were assessed by repeated measurements of anxiety, cortisol, heart rate, 
and heart rate variability.  
Results: The social support stress management was perceived as feasible and highly acceptable 
to participants. The intervention significantly reduced perceived stress in comparison to the 
control condition, but perceived stress levels returned to baseline at follow-up. Availability of 
social resources, levels of trait anxiety, relaxation and preoccupation did not differ significantly 
between the two conditions at any time. The standardized psychosocial stress test provoked a 
significant stress response, but conditions did not differ in any of the assessed physiological 
stress responses. However, participants in the social support stress management showed a 
significantly attenuated state anxiety response in comparison to those in the control condition.  
Conclusion: Our results indicated that our social support stress management intervention had 
a significant, albeit transient impact on perceived stress. The intervention had no effect on 
physiological responses to acute psychosocial stress, even though anxiety responses to stress 
were attenuated. Thus, the social support stress management had the expected – and stress-
buffering – effects on subjective parameters, but only as long as the social support was provided 
in terms of the intervention. Future research on social support stress management is of potential 
and should focus on the sustainablity of its effects as well as examine subjects reporting low 
levels of supportive social support and/or with clinical conditions.  
 
 
  
 Introduction 
While the ability to respond both physiologically and psychologically in the face of adversity 
is functional, enduring exposure to stress has a negative impact on mental and somatic health, 
partly mediated through its effects on the hypothalamic pituitary adrenal (HPA) axis as well as 
on sympathetic nervous system (SAM; McEwen, 2017). Accordingly and for example, stress 
has been associated with the incident of upper respiratory infections (Pedersen, Zachariae, & 
Bovbjerg, 2010), exacerbation in autoimmune diseases (Mohr, Hart, Julian, Cox, & Pelletier, 
2004; Porcelli et al., 2016), increased risk for coronary heart disease (Chida & Steptoe, 2010; 
Kivimäki et al., 2006), development of functional abdominal pain disorders (Korterink, 
Diederen, Benninga, & Tabbers, 2015), slower wound healing (Walburn, Vedhara, Hankins, 
Rixon, & Weinman, 2009) and depressive symptoms (Theorell et al., 2015). Considering that 
the high and increasing prevalence of stress – a survey in 2017 showed that 20% of respondents 
stated extreme stress in their daily lives and the percentage of experiencing at least one 
symptom of stress increased (American Psychological Association, 2017) – approaches to 
mitigate stress-related biological processes become a matter of public health.  
Here, a social perspective is warranted and of potential. In their seminal meta-analyis of 
208 laboratory studies, Dickerson and Kemeny (2004) identified uncontrollable social 
evaluation as the most potent stressor in terms of magnitude of the cortisol reaction and time to 
recovery. But while social interactions have the potential to be potent stressors when 
treathening one’s social esteem, acceptance or status (Dickerson, Gruenewald, & Kemeny, 
2009), social interactions can also contribute substantially to mental and physical health when 
perceived supportive. For example, Holt-Lunstad, Smith, and Layton (2010) reported a 50% 
increased likelihood of survival for elderly individuals with adequate socials relationships 
compared to those with poor or insufficient social relationships over an average of 7.5 years. 
These protective effects of social support can be explained through both modeling or 
encouraging healthy behavioural and psychological processes (DiMatteo, 2004) as well as 
buffering behavioural or physiological responses to acute or chronic stressors (e.g. Ditzen et 
al., 2007; Eisenberger, Taylor, Gable, Hilmert, & Lieberman, 2007; Nausheen, Gidron, Gregg, 
Tissarchondou, & Peveler, 2007; Thorsteinsson & James, 1999). 
However, interventions intended to manage stress have yet to explicitly encorporated a 
social perspective as they are predomently based on a intraindividual understanding of stress, 
i.e. with a focus on individual stress-related cognitions and behaviours (Gaab et al., 2003; 
Gloster et al., 2017; Hammerfald et al., 2006; Nyklíček, Mommersteeg, Van Beugen, 
Ramakers, & Van Boxtel, 2013; Storch, Gaab, Küttel, Stüssi, & Fend, 2007). To the contrary 
 and to the best of our knowledge, only one study evaluated the effects of an intervention 
employing the buffering effect of social support, albeit with no effects on an array of 
psychological parameters and symptoms as well as cardiovascular reactivity to a psychoscial 
stressor (Anthony & O’Brien, 2002).  
Thus, considering its protective and buffering effects, it seems promising to make use 
of social support in stress management interventions. Therefore, we set out to conceptualize, 
implement and evaluate the effects of a intervention intended to employ and improve social 
support skills and to reinforce the stress buffering effect of social support on 
psychoneuroendocrine stress responses.  
 
Methods 
Design 
A randomized controlled trial with an intervention and a waitlist control condition was 
conducted at the University of Basel, Switzerland. The study was carried out in accordance 
with the Declaration of Helsinki principles and the local ethic committee (Ethikkommission 
Nordwest- und Zentralschweiz) approved the study protocol (reference number EKNZ 2015-
005). All participants gave written informed consent. 
 
Participants 
The sample consisted of healthy women aged between 18 and 60. We included only women 
based on the assumption of gender differences in stress responses (Taylor et al., 2000), i.e. that 
women predominantly engage in a tend and befriend response to stress. Thus, we expected 
women to readily accept the rational of our intervention, which would facilitate the 
implementation of our social support stress management. Exclusion criteria were any current 
or chronic somatic diseases or psychiatric disorders assessed by self-report, current medication, 
being in psychological or psychiatric treatment, insufficient German language skills, previous 
participation in studies using the Trier Social Stress Test (TSST; Kirschbaum, Pirke, & 
Hellhammer, 1993) and smoking more than five cigarettes a day. 
 
Procedure 
Participants were recruited in lectures and via online advertisement at the University of Basel 
 and the University of Applied Sciences and Arts of Northwestern Switzerland. Interested 
women completed an online screening questionnaire. A total of 53 participants fulfilled 
inclusion criteria and were randomly allocated to the intervention or the waitlist control 
condition. Participants in the intervention condition received a two-week social support stress 
management (SSSM) in groups of 5-8 participants (week 2 and 3). In the waitlist control 
condition, participants received the intervention after study completion (after week 8). Self-
report questionnaires were completed online at baseline (week 1), post-intervention (week 4) 
and follow-up (week 8). Between the post and the follow-up assessment (week 5 to 7) all 
participants underwent a psychosocial stress test with assessement of psychological, 
neuroendocrine and cardiovascular stress responses.  
 
Intervention 
The SSSM was conceptualized to address the importance of social support for health and well-
being and to improve interpersonal skills to give and receive social support. Besides providing 
information on social support effects and its possible mechanisms, the SSSM focused on 
modeling supportive, non-judgemental communication between therapists and participants and 
on carrying out exercises in small groups to improve interpersonal communication skills. With 
this, the aim was to enhance the quality of interpersonal interactions and to allow personal and 
interpersonal exploration. Participants were encouraged to practice these skills in real life, i.e. 
between sessions, and to actively provide as well as ask for social support, since bi-directional 
support seems to be more effective in terms of well-being than just receiving support (Maton, 
1988). The intervention was based on a manual (for details, see Appendix 1) and adherence to 
the manual was supervised by a certified psychotherapist (JG). 
The intervention consisted of 16 training hours divided into six sessions with the first 
and the final session lasting four hours and the other four sessions two hours each. Each session 
focused on a different aspect of social support (see Appendix 1). All sessions took place within 
a two-week period. Two graduate students in clinical psychology (SH, SP) and a PhD student 
(NH) with substantial training and experience in psychotherapy conducted the SSSM in the 
intervention condition. In the control condition, the intervention was conducted by four 
graduate students (SH, SP, SA, FK) and a PhD student (NH). Graduate students were constantly 
supervised by the PhD student and all therapists were supervised weekly by a certified 
psychotherapist (JG). 
 
 Stress test 
The TSST (Kirschbaum et al., 1993) was conducted to induce psychosocial stress. The TSST 
consists of a simulated job interview followed by a mental arithmetic task (five minutes each) 
in front of an audience of two confederates. The TSST has repeatedly been found to induce 
profound endocrine and cardiovascular responses in 70–80% of the subjects tested (Kirschbaum 
et al., 1993). Psychological, neuroendocrine, and physiological data were collected before, 
during and after the test (for details see below). To account for circadian rhythm in cortisol 
secretion (Kirschbaum & Hellhammer, 1989), all TSSTs took place between 2 p.m. and 6 p.m.  
 
Measures 
Demographic data including age and body mass index (BMI) were assessed online together 
with the inclusion criteria before condition randomization took place. At baseline (week 1), 
post-intervention (week 4) and at follow-up (week 8) the following questionnaires were 
administered online: 
• The German version of the Perceived Stress Scale (PSS; Cohen, Kamarck, & 
Mermelstein, 1983), consisting of 14 items rated on a five-point scale, was used to 
assess the degree to which situations in the last few days have been appraised as 
stressful.  
• The German version of the State Trait Anxiety Inventory (STAI; Laux, Glanzmann, 
Schaffner, & Spielberger, 1982) was used to assess trait anxiety. The STAI trait form 
consists of 20 statements each to be rated on a four-point scale with a total score of 20-
37 interpreted as little or no anxiety, 38-44 as moderate anxiety and a score of 45-80 as 
extreme anxiety.  
• The German change-sensitive symptom list (ASS-SYM; Krampen, 2006) was 
employed to assess experience of relaxation, well-being, discomfort and preoccupation. 
The ASS-SYM has six subscales (physical and psychological exhaustion, nervousness 
and inner tension, psychophysiological deregulation, performance and behavioral 
problems, burden of pain, problems with self-determination and -control) with eight 
items each, rated on a four-point scale. Additionally a sum scale is calculated to reflect 
the general level of symptoms and problems.  
• The perceived and anticipated availability of social resources was assessed with the 
short version of the German Social Support Questionnaire (F-SozU K-22; Fydrich, 
Sommer, & Brähler, 2007). The FSozU K-22 includes 22 statements about the perceived 
 and anticipated availability of social resources to be rated on a five-point likert scale. It 
covers the dimensions emotional and practical support and social integration.  
At post-intervention assessment, two questionnaires were administered to the intervention 
condition to evaluate perceived group climate and therapeutic alliance:  
• The German version of the Group Climate Questionnaire - Short Form (GCQ-S; 
Tschuschke, Hess, & MacKenzie, 1991) was employed to assess perceived engagement 
(i.e. group cohesion, cognitive understanding, self-disclosure and empathy) and conflict 
(i.e. anger, detachment, confrontation and mistrust) with four items each.  
• The German version of the Working Alliance Inventory - short revised (WAI-SR; 
Wilmers et al., 2008) was employed to asses the therapeutic alliance, i.e. agreement on 
tasks, agreement on goals and development of an affective bond. The twelve items of 
the WAI-SR were rated on a five-point scale from 1 to 5. The wording of the 
questionnaire was adapted to fit our intervention (e.g. Johnson, Burlingame, Olsen, 
Davies, & Gleave, 2005).  
Furthermore, to assess physiological and emotional responses during and to the TSST, the 
following parameters were assessed: 
• To assess state anxiety before and after the TSST, the German version of the State Trait 
Anxiety Inventory (STAI; Laux et al., 1982) was administered before the TSST (-45 
minutes), after the introduction to the TSST (-20 minutes), immediately after the TSST 
(0 minutes) and in the recovery phase (50 minutes post TSST). 
• To assess salivary free cortisol levels, nine saliva samples were collected using Salivette 
collection devices (Sarstedt, Sevelen, Switzerland) at -45, -35, -25, -10, 0, 10, 20, 35 
and 50 minutes pre respectively post TSST. Sampling time lasted approximately one 
minute during which subjects chewed on the cotton swabs as regularly as possible. 
Salivettes were stored at −20°C until biochemical analysis took place. After thawing, 
biochemical analyses were conducted in the bio-chemical laboratory of the Clinical 
Psychology and Psychotherapy department at the University of Zurich, Switzerland, by 
means of a highly sensitive liquid chromatography–tandem mass spectrometry (LC–
MS/MS) method (Perogamvros et al., 2009). Since the use of oral contraceptives and 
the menstrual cycle phase has been shown to influence the activity of the HPA-axis and 
therefore the endocrine response to stress (Kirschbaum, Kudielka, Gaab, Schommer, & 
Hellhammer, 1999), participants reported the use of oral contraceptives, menstrual cycle 
length and the first day of their last menses. Based on these informations, menstrual 
 cycle phase, i.e. follicular or the luteal phase, on the day of the TSST was estimated. 
The follicular phase was defined as the period between the first day and 14 days before 
the end of the menstrual cycle, while the luteal phase was defined as the last 14 days of 
the cycle (Bouma, Riese, Ormel, Verhulst, & Oldehinkel, 2009). 
• Electrocardiography (ECG) was recorded continuously at 1000 Hz during one hour and 
40 minutes using the wireless physiological recording system BioNomadix® (Biopac 
Systems, Inc., Goleta, CA). Recorded ECG data were filtered using the software 
AcqKnowledge (Biopac Systems, Inc., Goleta, CA) with a FIR bandpass filter from 0.5 
Hz to 35 Hz with 8000 coefficients. The resulting heart period series were visually 
examined for artifacts and corrected when necessary using the VivoSense® software 
(Vivonoetics, Inc., San Diego, CA). To assess changes in heart rate over the course of 
the experiment seven mean heart rate slots of five minutes each were derived. Slots 
represented the mean heart rate at baseline (-30 to -25 minutes), in the preparation phase 
of the TSST, during the free speech in the TSST, during the mental arithmetic task in 
the TSST and in the recovery phase with three slots starting five, 15 and 25 minutes 
after the TSST ended. Furthermore, heart rate variability was calculated as RMSSD, the 
square root of the mean of the sum of the squares of differences between adjacent 
normal-to-normal intervals. This parameter is one of the most commonly used measure 
derived from interval differences (Berntson et al., 1997). Artefact corrections in one 
subject were over 10% and this data had therefore to be excluded from further analysis.  
 
Statistical Analysis 
All calculations were carried out using the statistic software IBMâ SPSSâ Statistics Version 
23. Data were tested for normal distribution and homogeneity of variance using the 
Kolmogorov-Smirnov test before statistical procedures were applied. When normal distribution 
was violated, calculations were repeated with log transformed data. For better readability, the 
original values were used for Tables and Figures. Two sample t-test were calculated to compare 
demographic characteristics and baseline values. Associations of age with psychometric or 
physiological measures were calculated as Pearson correlation coefficients. Descriptive 
statistics are presented for the GCQ and WAI measures. For the comparision of psychological 
variables over the course of the study, ANCOVAs for repeated measures were computed with 
age and baseline values as covariates and condition as between-subjects variable. All analyses 
were performed according to the principle of intention to treat (ITT), with last observations 
 carried forward when follow-up data were missing. All analyses were also run on subjects with 
complete datasets only, but results did not differ from ITT data (unless stated otherwise). For 
the analyses of stress responses to the TSST, ANCOVAS for repeated measures were computed 
to analyze changes of state anxiety, cortisol and ECG stress response with condition as between-
subjects variable and controlling for age and BMI. For effect sizes, parameters partial eta square 
were reported, where appropriate, according to the following conventions: 0.01 = small, 0.06 = 
medium, 0.13 = large (Cohen, 1988). Due to technical problems there was a loss of data from 
single subjects, resulting in different N (state anxiety N = 35; cortisol N = 37; HR and RMSSD 
N =  34). Two subjects had missing heart rate values at baseline, which were replaced with the 
arithmetical mean of the recovery values. Three subjects showed missing values in one or two 
recovery assessments which were replaced with the arithmetical mean of the available recovery 
values. Ten subjects had artifact corrections between 3 and 10%. Heart rate and RMSSD 
analyses were repeated with these ten subjects excluded, but results did not differ (data are not 
shown).  
All reported results were corrected by the Greenhouse-Geisser procedure when the 
sphericity assumption was violated. For state anxiety and cortisol responses areas under the 
response curve were calculated with respect to increase (AUCi) using the trapezoidal method 
as an indicator for the integrated response in the TSST (Pruessner, Kirschbaum, Meinlschmid, 
& Hellhammer, 2003). Distribution between conditions in use of hormonal contraceptives, 
menstrual cycle phase and frequency of non-responders were tested with Chi-square tests of 
independence. For all analyses, significance level was set at α = 5%.   
 
Results 
Sample characteristics and condition comparison at baseline  
In total, 53 subjects were randomly assigned to the intervention (N = 28) and control condition 
(N = 25). Due to withdrawal, insufficient intervention attendance, i.e. six h or less, and missing 
assessments the ITT sample with last observation carried forward consisted of N = 20 subjects 
in the intervention condition and N = 20 subjects in the control condition (for details see Figure 
1). N = 18 subjects in the intervention and N = 16 subjects in the control condition completed 
all assessments including the follow-up assessment. Three subjects of the ITT sample refused 
to participate in the TSST, resulting in cortisol samples of N = 20 in the intervention and N = 
17 in the control condition.  
  
Figure 1. Recruitment and participants flow through the study. 
 
Conditions differed in age (intervention condition M = 24.75, SD = 7.59; control condition M 
= 35.40, SD = 14.07, t(29.190) = -2.98, p = 0.006), but not in BMI (intervention condition M = 
21.31, SD = 1.88; control condition M = 21.17, SD = 3.19, t(38) = 0.18, p = 0.86) and question-
naires at baseline (see Table 1). Number of students did not differ between conditions 
(intervention condition N = 13/65%, control condition 12/60%, c2(1) = 0.11, p = 0.74). In the 
TSST, conditions did not differ in baseline cortisol (intervention condition M = 4.68, SD = 3.43; 
control condition M = 4.74, SD = 2.98, t(35) = -0.06, p = 0.95), heart rate (intervention condition 
M = 74.51, SD = 10.14; control condition M = 71.12, SD = 11.19, t(32) = 0.93, p = 0.36), 
RMSSD (intervention condition M = 53.10, SD = 23.88; control condition M = 42.53, SD = 
23.01, t(32) = 1.31, p = 0.20) and state anxiety level (STAI state; intervention condition M = 
38.15, SD = 8.50; control condition M = 35.53, SD = 5.16, t(35) = 1.11, p = 0.28). Age was 
negatively correlated with perceived stress (PSS) at baseline (r(38) = -0.36, p = 0.02) and avail-
ability of social support (FSozU K-22; r(38) = -0.39, p = 0.01) and positively with RMSSD at 
baseline (N = 34; r(32) = -0.54, p = 0.001). There were no significant correlations for age or 
BMI with cortisol (age r(35) = -0.13, p = 0.45; BMI r(35) = -0.01, p=0.95) and age with heart 
rate (r(32) = -0.07, p = 0.71), but a trend for a positive correlation for BMI with heart rate (r(32) 
= 0.30, p = 0.09) and a negative with RMSSD at baseline (r(32) = -0.32, p = 0.07). Use of oral 
 contraceptives (intervention condition N = 10/50%; control condition N = 4/24%, c2(1) = 2.74, 
p = 0.10) as well as number of women in the follicular phase (intervention condition 8/40%; 
control condition N = 6/35%, c2(1) = 0.09, p = 0.77) did not differ between conditions.  
 
Participation, attendance and evaluation of the intervention 
Twenty-eight women were allocated to the intervention condition, two refused participation 
after randomization and five had to be excluded from analysis due to insufficient intervention 
attendance of six hours or less. The mean intervention attendance of the 21 subjects with 
sufficient intervention attendance was 12.38 hours (SD = 2.59).  
Results of the GCQ-S indiated high levels of engagement (M = 4.93, SD = 0.62) and 
very little interpersonal conflict (M = 0.49, SD = 0.63). Furthermore, the overall alliance (WAI-
SR) with therapists (M = 3.40, SD = 0.58) and participants in the SSSM condition (M = 3.41, 
SD = 0.54) was good and comparable. On the three subscales, development of an affective bond 
was rated high (M = 4.05, SD = 0.58 for therapists, M = 3.98, SD = 0.34 for participants), ratings 
for agreement on tasks and agreement on goals were one point lower on the likert scale (task M 
= 3.08, SD = 0.87 for therapists, M = 3.18, SD = 0.84 for participants; goal M = 3.09, SD = 0.70 
for therapists, M = 3.08, SD = 0.81 for participants).  
 
Comparisons of psychological variables over the course of the study 
The intervention led to significant, albeit transient reductions in perceived stress (PSS) over the 
course of the study (F(2,72) = 4.09, p = 0.02, partial eta square = 0.10), with a reduction of 
post-intervention PSS scores in the intervention condition and a return to baseline levels at 
follow-up and no changes in the control condition (see Table 1). Conditions did not differ in 
any other psychological variables over the course of the study (STAI trait: F(2, 72) = 0.45, p = 
0.64; ASS-SYM: F(2, 72) = 0.66, p = 0.52; FSozU K-22: F(2, 72) = 2.23, p = 0.12; see Table 
1). 
 
 
 
 
 
 Table 1. Condition differences in psychological variables over the course of the study 
 Intervention condition (N = 20) Control condition (N = 20) 
 Baseline Post Follow-up Baseline Post Follow-up 
PSS 23.85 (6.45) 19.35 (5.51) 22.95 (7.51) 19.80 (8.43) 20.95 (9.30) 19.25 (7.74) 
STAI trait 37.65 (7.65) 36.95 (8.07) 37.75 (9.22) 35.40 (9.18) 36.35 (10.19) 35.60 (9.29) 
ASS-SYM 37.00 (17.50) 32.75 (16.40) 37.35 (20.62) 31.35 (19.25) 30.35 (20.68) 31.05 (20.78) 
FSozU K-22 4.55 (0.32) 4.57 (0.33) 4.62 (0.23) 4.41 (0.50) 4.34 (0.55) 4.33 (0.58) 
 
 
Stress responses 
Participants completing the TSST (n = 37) had a mean age of 29.51 years (SD = 12.50) and a 
mean BMI of 21.23 kg/m2 (SD = 2.68). There was no significant difference in BMI between 
the two groups (t(23.84) = -.11, p = .914). However, there was a significant group difference in 
age with subjects in the control group being significantly older than subjects in the intervention 
condition (t(19.15) = -3.57, p = .002); intervention condition M = 23.35, SD = 5.03, waitlist 
control condition M = 36.76, SD = 14.77). 
With regard to STAI state anxiety responses to the TSST, participants in the the 
intervention condition showed a clear trend to an attenuated response over time (N = 35, F(2.87, 
91.81) = 2.59, p = 0.06, partial eta square = 0.08; see Figure 2) as well as a significant lower 
integrated response in comparison to controls (AUCi: intervention condition M = 153.21, SD = 
515.26, control condition M = 592.63, SD = 910.22; F(1, 32) = 5.51, p = 0.03, partial eta square 
= 0.15). However, cortisol responses over times as well as integrated cortisol responses did not 
differ signifcantly between conditions (F(2.02, 66.65) = 0.25, p = 0.78; see Figure 2; AUCi: 
intervention condition M = 53.51, SD = 198.18, control condition M = 38.89, SD = 171.01; F(1, 
33) = 0.11, p = 0.74). Conditions did not differ in the prevalence of cortisol non-responders 
(AUCi ≤ 0: control condition N = 7, 41%; intervention condition N = 7, 35%; c2(1) = 0.15, p = 
0.70). Also, participants in both conditions did not differ significantly in their heart rate (F(1.69, 
50.63) = 0.67, p = 0.49) nor in RMSSD responses to the TSST (F(1.99, 59.56) = 0.65, p = 0.53; 
see Figure 3).  
 Figure 2. Cortisol and state anxiety responses in the Trier Social Stress Test (TSST) between conditions 
(means and standard error means). Intervention condition = black circle, control condition = grey square.  
 
 
 
 
 
Figure 3. Heart rate and Root Mean Square of Successive Differences (RMSSD) response in the Trier 
Social Stress Test (TSST) between conditions (means and standard error means). Intervention condition 
= black circle, control condition = grey square.  
 
Discussion 
The goal of the study was to implement and evaluate a social support stress management 
intervention intended to employ and improve social support skills and to reinforce the stress 
buffering effect of social support on psychological parameters and physiological stress 
responses in healthy women. The intervention was favourably rated by participants and led to 
a significant – albeit transient – reduction in perceived stress. Although some improvements in 
 the availability of social resources, levels of trait anxiety, relaxation and preoccupation were 
reported after the intervention, none of them were significant when compared to the control 
condition. Also, conditions did not differ in their cortisol, heart rate and heart rate variability 
responses to the standardized psychosocial stress test, but participants in the intervention 
condition showed a significantly attenuated state anxiety response in comparison to those in the 
control condition.  
The newly conceptualized social support stress management intervention was perceived 
as practicable in terms of length and effort as well as generally rated very positive, with high 
engagement and low conflict rating, at least when compared with group psychotherapy 
(Bormann & Strauß, 2007; Hecke, Brand, Rietz, & Schultz-Venrath, 2016). Also, ratings of 
bond with psychologists and participants in the intervention condition were high and 
comparable to those found in other studies (Munder, Wilmers, Leonhart, Linster, & Barth, 
2010). However, ratings of agreement on tasks and goals were rather low, possibly due to the 
focus of the intervention laying on supportive interaction and not on defining individual tasks 
and goals.  
The intervention led to increased levels of perceived social support whereas participants 
of the control condition showed a decrease in this measure, but this observation was rather 
moderate and not significant. This differs from trials testing other interventions to strengthen 
social support, which found trends (Anthony & O’Brien, 2002) or significant improvement in 
social support measures (Brand, Lakey, & Berman, 1995; Martin, Reece, Lauder, & 
McClelland, 2011). However, although this studies shared some similarities with our study, 
such as inclusion of healthy participants and the aim to improve and practice social skills, these 
studies only included individuals scoring low on social support measures and also included 
male participants. In contrast, our sample had already high baseline ratings in perceived social 
support, with scores 12% above those reported in a normative sample of healthy subjects 
(Fydrich et al., 2007). Thus, the lack of any effect on social support measures in our participants 
is possibly a consequence of already high social support levels at baseline.  
With regard to perceived stress, the social support stress management led to a significant 
reduction of perceived stress of medium to large effect size, but which also returned to baseline 
levels at follow-up. These findings partly correspond to previous evaluations of stress 
management trainings, which similarly reported reduced levels of perceived stress after the 
training, but were based on different theoretical premises (Gaab et al., 2003; Storch et al., 2007). 
However, not all interventions based on intraindividual stress management could find an effect 
of the intervention on perceived stress (Gloster et al., 2017) and also trainings intended to 
 improve social support so far failed to show an effect on daily stress or perceived work stress 
(Anthony & O’Brien, 2002; Sallis, Trevorrow, Johnson, Hovell, & Kaplan, 1987). Assumably, 
our intervention helped participants to reduce stress by giving the opportunity to interact with 
each other in a supportive way during the intervention, but this did not lead to lasting changes 
in behaviour and transfer into daily life. A comparision with other interventions improving 
social support skills is difficult, as most testing did not inlcude a follow-up. Of the 13 studies 
rewied by Hogan, Linden and Najarian (2002) on social support skills group trainings, only 
four of 13 studies inlcuded a follow-up, of which three reported effects to be maintained at 
follow-up three or six months later (Monti, Curran, Corriveau, DeLancey, & Hagerman, 1980; 
Stravynski, Belisle, Marcouiller, Lavallée, & Eue, 1994; van Dam-Baggen & Kraaimaat, 1986). 
It has to be taken into account that the studies showing long-term effects were conducted on a 
population with psychiatric disorders and having considerable deficits in social skills. To the 
best of our knowledge only one study found positive effects of a social support training 
maintained at the follow-up tem weeks later in non-clinical subjects, which, however, scored 
low on social support measures (Martin et al., 2011). It is possible that individuals with 
considerable deficits in social skills and social support would profit from similar trainings and 
be able to transfer trained skills into their everyday life.  
The TSST elicited an increase in state anxiety, cortisol, heart rate and a decrease in 
RMSSD. But while heart rate responses to the TSST were comparable to those found in other 
studies (Ditzen et al., 2007; Kudielka, Buske-Kirschbaum, Hellhammer, & Kirschbaum, 2004), 
cortisol responses have to be considered as below the norm (i.e. with increases of 50% to 150%; 
Kudielka, Hellhammer, & Wüst, 2009) and 14 subjects of our sample were cortisol non-
responders. This is possibly due to the inclusion of women on oral contraceptives and in the 
follicular phase of the menstrual cycle (Kirschbaum et al., 1999) and that our participants, of 
which more than half were students, were used to hold presentations or speak in public (Engert 
et al., 2013).  
When comparing the intervention to the control condition, there were no differences in 
their physiological reaction to the TSST, indicating no effect of the intervention on acute stress 
responses. While some of previous stress management trainings with a clear intraindividual 
focus found effects on the cortisol response to acute stress (Gaab et al., 2003; Hammerfald et 
al., 2006; Storch et al., 2007), others did not (Gloster et al., 2017) as well as trainings based on 
social support failed to find such effects (Anthony & O’Brien, 2002; Sallis et al., 1987). With 
regard to our intervention, this finding is possible due to the protocol of the TSST, which clearly 
prevents any possibility to use or obtain social support, as the audience of confederates is 
 instructed to interact in a neutral way with the participants and not to give any positive verbal 
or non-verbal feedback or signs of communication other than that specified in the manual 
(Kirschbaum et al., 1993). All efforts of participants to interact with members of the audience 
in possible supportive way were therefore unsucessful and otherwise stress-reducing social 
skills could not be applied. To test the potential of similar social support stress managements 
to reduce psychophysiological responses in stressful situations, the latter should strive for 
ecological validity and thus offer opportunities for positive interactions, as many studies 
indicate that positive social interactions before or during a psychosocial stress test can reduce 
endocrine and cardiovascular reactivity to the stressor (Christenfeld et al., 1997; Ditzen et al., 
2007; Kirschbaum, Klauer, Filipp, & Hellhammer, 1995; Lepore, 1995; Lepore, Allen, & 
Evans, 1993; Uchino & Garvey, 1997). 
The following limitations have to be considered when interpreting the results of our 
study. First, there was a significant difference in age between the two conditions, which was 
accounted for by including age as a control variable in all calculations. Second, the sample size 
was rather small, limiting the statistical power to detect small condition differences, but 
adequate to detect the effects sizes previously reported. Third, the central assumption of women 
being more likely to mobilize social support in times of stress and investing more in their social 
relationships than men (Taylor, 2011) has recently been challenged as there is evidence for men 
also showing an increase in prosocial behaviour during stress (von Dawans, Fischbacher, 
Kirschbaum, Fehr, & Heinrichs, 2012). It would thus be interesting to investigate the effects of 
similar interventions in men and to compare them with effects in women. 
In summary, our social support stress management in healthy women was successful in 
terms of feasibility and applicability and had short-term effects on subjectively reported 
perceived stress. Further evaluation on subjects reporting low levels of supportive social 
interactions could elucidate if the intervention can sustainably improve social support. 
Although research has clearly shown that social support has a notable impact on morbidity and 
mortality, it rests fairly unclear if these effects can be harnessed in a more systematic way. 
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 Appendix 1: Abrigded manual of the social support stress management 
General comments to therapists 
The goal of the intervention is to impart interpersonal skills to deal with stress and give partic-
ipants opportunities to train these skills. Most likely these skills are not completely new and at 
least partially already available. Important is to stress their importance, to implement and try 
them out in a safe space under professional supervision. The therapists model supportive inter-
actions by communicating openly, empathic and validating to each other and to the participants. 
Problems are handled in a solution-focused way with emphasis on the question what was or 
could be helpful. Topics will be first discussed on the basis of personal experience and then in 
the context of scientific studies and models. At the end of each session, participants share their 
experiences of the session, verbalize what they take home from the session and what they could 
try out in the next few days. 
 
Summary of the six sessions 
The goal of the first session (four hours) is to introduce and discuss the aim of the intervention 
and to train basic communication skills. In the first module (60 minutes), participants discuss 
what puts them under stress and what helps them to cope with stress. Therapists seek to put the 
results of the discussion in context of findings on social evaluative threat and the social dimen-
sion of stress (Dickerson & Kemeny, 2004), on social support (Holt-Lunstad et al., 2010) and 
the assumption of gender-specific coping (Taylor et al., 2000). In the second module (90 
minutes), participants and therapists play a board game involving personal questions. The goal 
of the game is to create a relaxed atmosphere where participants and therapists can get to know 
each other. In the third module, participants are invited to discuss and practice determinants of 
good communication, such as empathy, authenticity and unconditional appreciation (90 
minutes).  
The goal of the second session (two hours) is to improve the perception and communi-
cation of one’s own feelings (Gendlin, 1982) as a basis for supportive communication. For this 
purpose, participants are introduced to simple exercises to monitor somatic representations of 
emotional experiences, which are first demonstrated to the whole group under the guidance of 
a therapist and then exercised in small groups. 
The goal of the third session (two hours) is to focus on one’s own social network and 
the different forms of social support that are enacted in this network, especially when under 
 stress (Cohen & Wills, 1985). Participants discuss different forms of support and create an il-
lustration of their network. They discuss how their social ties are affected by stress and how 
and with whom they can increase beneficial social interactions. 
The goal of the forth session (two hours) is to address self-disclosure and being vulner-
able in social interactions in the delicate balance between feeling threatened by anticipated and 
real social rejection and the relieving experience to share problematic experience with others. 
These topics are discussed on the basis of personal experiences and with references to Learys 
sociometer theory (Leary, Tambor, Terdal, & Downs, 1995).  
The goal of the fifth session (two hours) is to differentiate between different types and 
consequences of stress and how to utilize social support when under stress. In the first module 
(60 minutes), participants and therapists discuss differences between acute and chronic as well 
as functional and health-impacting stress. In the second module (60 minutes), the use of imag-
ined persons as social support in times when no-one is directly available is discussed and expe-
riences with this are shared with the group. 
The goal of the sixth session (four hours) is, beside the presentation of one new aspect 
of social support, the review and repetition of contents of the intervention. In the first module 
(60 minutes), the relevance and importance of physical contact as a form of social support is 
discussed on the basis of personal experience and scientific research (Ditzen et al., 2007). In 
the second module (30 minutes), participants discuss what was important for them and possible 
changes they made during the intervention in small groups. In the closing module (90 minutes), 
the game from the first session is played again, this time with questions focused on experiences 
made during the intervention. A feedback round concludes the intervention (60 minutes).  
 
